Disorders of the thyroid gland

E4_THYROID

thyroid nodule: A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter (GOITER, NODULAR).

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E00-E07 Cause of death: ICD-10 — E00-E07 2 out of 7 registries used, show all original rules.	41682
4. Check minimum number of events None	41682
5. Include endpoints E4_CONGEIOD E4_IODGOITRE E4_IODTHYR E4_IODHYPSUB E4_HYTHYSUBS E4_HYTHYPOSTINF E4_ATROTHY E4_MYXOCO E4_HYTHYNAS E4_GOITREDIFF E4_GOITRENOD E4_GOITREMULTINOD E4_GOITRENAS E4_THYTOXGOITDIF E4_THYTOXECT E4_THYCRISIS E4_THYTOXNAS E4_THYROIDITACU E4_THYROIDITSUBAC E4_THYROIDITCHRON E4_THYROIDITAUTOIM E4_THYROIDITDRUG E4_THYROIDITNAS E4_HYPERSECCAL E4_GOITREDYS E4_THYROIDNASOTH	78743
6. Filter based on genotype QC (FinnGen only)	78743

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	E4_THYROID
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_CONGEIOD\|E4_IODGOITRE\|E4_IODTHYR\|E4_IODHYPSUB\|E4_HYTHYSUBS\|E4_HYTHYPOSTINF\|E4_ATROTHY\|E4_MYXOCO\|E4_HYTHYNAS\|E4_GOITREDIFF\|E4_GOITRENOD\|E4_GOITREMULTINOD\|E4_GOITRENAS\|E4_THYTOXGOITDIF\|E4_THYTOXECT\|E4_THYCRISIS\|E4_THYTOXNAS\|E4_THYROIDITACU\|E4_THYROIDITSUBAC\|E4_THYROIDITCHRON\|E4_THYROIDITAUTOIM\|E4_THYROIDITDRUG\|E4_THYROIDITNAS\|E4_HYPERSECCAL\|E4_GOITREDYS\|E4_THYROIDNASOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E0
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E0
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of the thyroid gland based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	566613	446419	116533
Only index persons	517238	412052	105186
Unadjusted period prevalence (%)
Whole population	10.77	12.79	3.26
Only index persons	12.88	15.15	4.02
Median age at first event (years)
Whole population	54.73	53.73	58.77
Only index persons	53.71	52.65	57.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	78743	62488	16255
Unadjusted period prevalence (%)	18.38	21.30	7.17
Median age at first event (years)	51.99	50.01	59.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21233: Matched controls
187041

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

618.4

323.0

615

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

24.1

323.0

944

360

H03AA01

ATC

levothyroxine sodium; systemic

623.9

323.0

17647

1475

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

1194.5

323.0

1513

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

109.8

323.0

629

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

62.1

323.0

584

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

121.2

323.0

602

E03.89

ICD-10 Finland

Other specified hypothyroidism

209.7

323.0

1587

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

156.8

323.0

521

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

23.3

323.0

566

219

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

385.8

323.0

1515

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

427.5

323.0

7550

241

BAA60

NOMESCO Finland

Total thyroidectomy

466.9

323.0

1110

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

231.9

323.0

1170

104

Kela drug reimbursment

Thyroid insufficiency

973.2

323.0

3356

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.4

323.0

1404

2942

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

67.2

323.0

404

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

63.6

323.0

741

106

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

611.3

323.0

476

E03

ICD-10 Finland

Other hypothyroidism

215.0

323.0

2781

131

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

25.8

323.0

476

166

H03BB01

ATC

carbimazole; oral

266.9

323.0

2296

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

433.4

323.0

1300

T86

ICPC

Hypothyroidism/myxoedema

159.9

323.0

1827

110

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

1065.1

323.0

357

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

340.9

290.3

307

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

278.3

280

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

17.3

278.3

465

242

E06.3

ICD-10 Finland

Autoimmune thyroiditis

74.7

259.0

309

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

1166.7

255.0

261

E23.00

ICD-10 Finland

Panhypopituitarism

44.9

237.5

307

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

93.8

226.7

263

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

1970.9

226.2

230

E05.89

ICD-10 Finland

Other thyrotoxicosis

678.5

221.4

229

N02BE01

ATC

paracetamol; systemic, rectal

1.7

221.1

16277

123651

H02AB09

ATC

hydrocortisone; systemic

5.7

215.4

666

1054

101

Kela drug reimbursment

Anterior pituitary hypofunction

13.8

211.9

386

250

C07AA05

ATC

propranolol; systemic

2.0

211.9

3334

16164

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

198.7

3942

20716

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

144.4

189.6

211

N05AH04

ATC

quetiapine; oral

1.9

185.8

3318

16771

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

+∞

173.8

175

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

172.8

174

R53

ICD-10 Finland

Malaise and fatigue

1.7

164.7

3753

20467

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

164.1

7850

51991

N06AX11

ATC

mirtazapine; oral

1.6

161.2

5157

30940

A02BC02

ATC

pantoprazole; systemic

1.5

156.8

10884

77837

N05BA04

ATC

oxazepam; oral

1.7

154.9

4097

23297

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

+∞

153.9

155

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

8.3

153.2

362

391

J01DB01

ATC

cefalexin; oral

1.5

148.7

15768

122534

N06AX16

ATC

venlafaxine; oral

2.0

145.1

2216

10494

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

144.6

7654

51403

C01BD01

ATC

amiodarone; systemic

3.3

142.3

766

2066

T85

ICPC

Hyperthyroidism/thyrotoxicosis

48.2

140.6

179

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

138.9

1063

3626

N06AB10

ATC

escitalopram; oral

1.7

137.0

3468

19382

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.5

134.2

674

1722

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

610.5

133.1

138

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.1

132.7

1626

7030

SPAT1263

SPAT

Sampling

1.5

132.7

8064

55413

N06AB04

ATC

citalopram; systemic

1.7

128.3

3279

18341

SPAT1262

SPAT

Handing over of treatment supplies

1.7

127.4

3455

19643

R03AC02

ATC

salbutamol; inhalant

1.4

123.4

8806

62138

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

122.1

1365

5657

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

119.9

4289

26132

H02AB06

ATC

prednisolone; systemic

1.4

119.3

7842

54361

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

190.5

118.5

129

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.1

116.1

679

1943

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

114.3

6035

39989

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

114.3

5156

33059

T89

ICPC

Diabetes insulin dependent

2.6

114.0

887

3049

C07AB07

ATC

bisoprolol; oral

1.4

113.9

7775

54134

E06.9

ICD-10 Finland

Thyroiditis, unspecified

90.0

113.6

132

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

6.8

113.2

302

393

N06AB06

ATC

sertraline; oral

1.9

111.9

1859

9032

H04AA01

ATC

glucagon; nasal, parenteral

3.1

111.7

654

1872

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

110.4

2259

11769

N06AX12

ATC

bupropion; oral

2.2

109.5

1169

4738

SPAT1301

SPAT

No procedures

1.5

109.1

5779

38232

N05AN01

ATC

lithium; oral

3.5

109.0

557

1442

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

17.0

106.7

178

R06.0

ICD-10 Finland

Dyspnoea

1.5

106.5

3995

24520

A10AE04

ATC

insulin glargine; parenteral

1.8

104.0

1870

9327

4CJ01

NOMESCO Finland

476.6

103.5

108

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

103.3

1551

7251

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

95.8

103.2

119

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

102.7

4476

28370

E03.8

ICD-10 Finland

Other specified hypothyroidism

472.1

102.5

107

A98

ICPC

Health maint/preventive medicine

1.6

101.5

19005

157341

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

101.2

1583

7512

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

100.4

1838

9219

G47.3

ICD-10 Finland

Sleep apnoea

1.5

98.6

3729

22873

E23.05

ICD-10 Finland

Lack of TSH

51.9

98.1

123

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

98.0

2694

15262

A10AE05

ATC

insulin detemir; parenteral

2.1

97.0

1143

4838

N03AX09

ATC

lamotrigine; oral

2.4

96.1

901

3423

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.5

94.9

800

2874

WX110

NOMESCO Finland

Local anesthesy

1.4

94.9

12645

97378

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

94.8

4406

28230

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

153.4

94.2

104

N05CF01

ATC

zopiclone; oral

1.4

93.4

4808

31435

N03AG01

ATC

valproic acid; systemic, rectal

2.2

93.3

1086

4571

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

92.9

4738

30918

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

92.7

1229

5464

N06AX21

ATC

duloxetine; oral

1.9

92.7

1432

6757

J01CA04

ATC

amoxicillin; systemic

1.4

92.6

15342

122149

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

91.5

4343

27916

A04

ICPC

Weakness/tiredness general

1.7

91.2

2309

12773

J02AC01

ATC

fluconazole; systemic

1.5

91.1

4561

29635

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

101.3

89.9

103

SPAT1312

SPAT

General health counselling

1.4

89.9

6075

41735

E03.1

ICD-10 Finland

Congenital hypothyroidism without goitre

812.8

89.4

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.6

89.2

698

2404

2504

FHL

Unilateral resection or enucleation

45.9

89.1

114

SPAT1310

SPAT

Counselling related to known health issue

1.4

87.8

5771

39410

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

87.3

3375

20732

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

86.8

1347

6360

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

86.4

5977

41159

R01AD09

ATC

mometasone; nasal

1.4

85.6

6910

48827

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

85.1

561

1741

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

87.6

85.1

A02BC05

ATC

esomeprazole; systemic

1.4

84.7

5845

40205

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

11.2

84.6

168

133

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

86.7

84.1

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

82.6

3114

18995

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

82.1

786

3014

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

81.9

12570

97720

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

80.5

3668

23297

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

254.9

80.4

N05AH03

ATC

olanzapine; systemic

2.0

80.4

1084

4848

E66.8

ICD-10 Finland

Other obesity

2.4

80.1

742

2800

SPAT1260

SPAT

Consultation of another employee

1.5

79.8

3017

18403

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

79.1

1469

7379

R06AE07

ATC

cetirizine; oral

1.4

78.9

6647

47131

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

78.7

7153

51316

M79.6

ICD-10 Finland

Pain in limb

1.4

78.5

5143

34959

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

78.5

2432

14149

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

77.9

3088

19026

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.4

77.8

412

1097

2411A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic multinodular goitre

+∞

77.4

R01AD12

ATC

fluticasone furoate; nasal

1.4

76.9

4493

29901

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

76.8

7379

53336

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.1

76.2

321

706

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

351.7

75.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

75.7

7239

52252

M14.5*E03.9

ICD-10 Finland

Arthropathy in hypothyroidism (E00-E03+)

688.4

75.5

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

75.5

2862

17448

N03AX16

ATC

pregabalin; oral

1.5

75.3

3194

19953

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

75.2

2282

13195

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.1

75.2

313

681

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

74.5

904

3868

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

74.4

8757

65119

E0000UV

ATC

1.3

74.1

6416

45567

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

4.5

73.8

279

553

A10AA01

ATC

2.7

73.4

547

1831

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.3

73.0

392

1055

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

73.0

3258

20550

N05AX12

ATC

aripiprazole; systemic

2.3

72.8

742

2931

N05AX08

ATC

risperidone; systemic

1.8

72.5

1359

6839

R51.80

ICD-10 Finland

Headache

1.6

71.9

2276

13287

T82

ICPC

Obesity

2.6

71.9

560

1923

SPAT1240

SPAT

Therapeutic discussion

1.6

71.9

1993

11253

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

71.8

2868

17667

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

71.4

4852

33091

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

71.1

9112

68411

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

71.1

957

4271

K02.1

ICD-10 Finland

Caries of dentine

1.3

70.6

10183

77674

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

70.0

495

1605

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

69.6

5604

39262

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

69.4

N06AB03

ATC

fluoxetine; oral

1.7

69.0

1728

9486

T90

ICPC

Diabetes non-insulin dependent

1.4

68.5

3642

23741

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

67.5

5427

37971

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

+∞

67.5

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

67.4

1271

6403

E04.8

ICD-10 Finland

Other specified nontoxic goitre

65.2

67.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

66.7

7351

53875

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

66.5

2386

14330

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

66.5

4343

29355

AA1AD

NOMESCO Finland

CT of head and brain

1.4

66.5

3686

24201

A02BC01

ATC

omeprazole; systemic

1.4

66.4

4283

28890

C03CA01

ATC

furosemide; systemic

1.4

66.1

4474

30422

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

65.8

2296

13698

G03DB01

ATC

dydrogesterone; oral

2.0

65.6

860

3799

ZXE00

NOMESCO Finland

One hour or less

1.3

65.4

6565

47440

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

64.6

11394

88779

P76

ICPC

Depressive disorder

1.9

64.6

1051

5035

M25.5

ICD-10 Finland

Pain in joint

1.4

64.6

3791

25134

H3600, E103

ICD-10 Finland

3.8

64.5

288

668

Z71.8

ICD-10 Finland

Other specified counselling

1.4

64.5

3935

26268

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

64.4

580

2156

S18

ICPC

Laceration/cut

1.3

64.4

6791

49397

N05BA01

ATC

diazepam; systemic, rectal

1.6

64.3

1911

10964

W84

ICPC

Pregnancy high risk

2.1

64.3

802

3470

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

64.2

9112

69001

M54.5

ICD-10 Finland

Low back pain

1.4

64.2

4889

33863

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

63.8

1604

8807

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

50.5

63.8

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.7

63.4

295

709

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

6.1

63.4

182

264

A10BA02

ATC

metformin; oral

1.4

63.0

4615

31752

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

62.7

814

3577

2449X

ICD-9 Finland

Acquired hypothyroidism, Unspecified hypothyroidism

+∞

62.5

R42

ICD-10 Finland

Dizziness and giddiness

1.4

61.6

3018

19323

SPAT1153

SPAT

Removal of sutures

1.3

61.5

4993

34888

J01CA08

ATC

pivmecillinam; oral

1.4

61.4

3587

23733

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.5

61.0

308

792

J01AA02

ATC

doxycycline; systemic

1.3

60.8

12658

100343

R01AD08

ATC

fluticasone; nasal

1.4

60.3

4117

27971

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

59.8

1130

5693

SPAT1325

SPAT

Vaccination

1.3

59.7

5715

40891

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

59.2

3461

22884

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.7

59.1

423

1384

106

Kela drug reimbursment

Hypoparathyroidism

25.9

58.7

E03.82

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

+∞

58.5

A10AA02

ATC

2.2

58.4

637

2599

A10AE06

ATC

insulin degludec; parenteral

2.4

58.2

548

2084

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

58.0

833

3811

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

57.8

3907

26469

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

57.5

2635

16636

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

57.2

2208

13447

L03

ICPC

Low back symptom/complaint

1.4

56.8

3484

23210

Z01.2

ICD-10 Finland

Dental examination

1.3

56.3

6608

48530

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

56.3

2220

13583

N05AA02

ATC

levomepromazine; systemic

2.0

56.2

725

3179

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.7

56.1

396

1284

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.4

55.5

285

743

Z3231

NOMESCO Finland

Registered nurse

1.3

55.4

4493

31299

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.7

55.1

1135

5874

F34.1

ICD-10 Finland

Dysthymia

2.3

55.1

542

2104

G44.2

ICD-10 Finland

Tension-type headache

1.6

55.1

1670

9613

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

9.0

55.1

122

120

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

502.0

54.8

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

54.8

363

1131

R50.9

ICD-10 Finland

Fever, unspecified

1.5

54.8

2428

15210

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.7

54.8

1367

7480

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

54.7

3716

25168

ZX114

NOMESCO Finland

Intramuscular

3.5

54.1

270

689

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

53.2

7914

59780

N06AX26

ATC

vortioxetine; oral

1.9

53.0

879

4238

A11CC03

ATC

alfacalcidol; systemic

2.5

52.8

438

1560

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

52.6

9390

72464

N05CF02

ATC

zolpidem; oral

1.5

52.4

2170

13401

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.2

52.4

582

2394

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.4

52.3

2425

15320

H01AC01

ATC

somatropin; parenteral

8.1

51.9

122

133

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

51.7

1127

5930

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

+∞

51.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

51.6

12860

103049

ZY010

NOMESCO Finland

Hospital outpatient

1.9

51.5

864

4179

M01AE02

ATC

naproxen; oral, rectal

1.3

51.4

9303

71829

SPAT1379

SPAT

Health check-up of pregnant person

1.4

51.3

2635

16975

102

Kela drug reimbursment

Diabetes insipidus

16.7

51.1

L17

ICPC

Foot/toe symptom/complaint

1.4

50.9

3598

24484

M03BX02

ATC

tizanidine; oral

1.2

50.3

9272

71671

B01AB05

ATC

enoxaparin; parenteral

1.3

49.5

4241

29702

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

49.0

2729

17825

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

48.9

16595

137479

24409

ICD-8 Finland

Myxoedema, (hypothyreosis) NUD

448.7

48.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

48.7

1224

6706

P03

ICPC

Feeling depressed

1.5

48.7

1586

9280

P01AB01

ATC

metronidazole; oral, rectal

1.3

48.1

5255

38048

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

48.1

2418

15495

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

48.0

1766

10623

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

47.7

5798

42555

A06AD11

ATC

lactulose; oral

1.4

47.7

2162

13581

R13

ICD-10 Finland

Dysphagia

1.8

47.3

900

4541

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.2

47.1

518

2121

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.4

47.0

2991

19979

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.7

47.0

1075

5735

UJF32

NOMESCO Finland

Coloscopy

1.3

47.0

3600

24772

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

46.8

1241

6893

R11

ICD-10 Finland

Nausea and vomiting

1.6

46.8

1190

6537

F31

ICD-10 Finland

Bipolar affective disorder

3.3

46.7

246

655

ZXD05

NOMESCO Finland

Urgent procedure

1.3

46.7

5461

39862

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

+∞

46.6

J01DA01

ATC

[U] cefalexin; systemic

1.2

46.5

10373

81613

SPAT1254

SPAT

Administration of medicine

1.4

46.5

2448

15816

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.0

45.9

192

422

N97.9

ICD-10 Finland

Female infertility, unspecified

1.9

45.8

690

3210

J01FA10

ATC

azithromycin; systemic

1.2

45.8

9184

71377

G03GA01

ATC

chorionic gonadotrophin; parenteral

2.4

45.7

413

1539

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.9

45.5

200

460

L28

ICPC

Limited function/disability (L)

1.5

45.5

2022

12643

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

19.6

45.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

45.0

1848

11371

SPAT1216

SPAT

Assessment of functional ability

1.4

45.0

2093

13204

E06.4

ICD-10 Finland

Drug-induced thyroiditis

413.2

45.0

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

44.8

560

2425

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

44.2

4906

35523

W78

ICPC

Pregnancy

1.3

44.1

3118

21167

H03BA02

ATC

propylthiouracil; oral

404.4

44.0

N05BA12

ATC

alprazolam; oral

1.6

44.0

1241

7005

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

43.9

1761

10781

KMAK

NOMESCO Finland

1.2

43.8

8661

67091

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

+∞

43.6

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

43.3

1622

9785

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.3

43.2

228

609

D82

ICPC

Teeth/gum disease

1.3

43.0

5631

41592

N06AB05

ATC

paroxetine; oral

1.8

42.9

788

3931

WX290

NOMESCO Finland

Other blockade of nerve

1.2

42.9

7733

59254

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

42.8

1509

8977

R00.2

ICD-10 Finland

Palpitations

1.8

42.7

852

4362

24220

ICD-8 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre

+∞

42.7

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

2.4

42.6

386

1441

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

42.4

2029

12862

E06.0

ICD-10 Finland

Acute thyroiditis

64.4

42.4

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

42.3

1428

8416

N03AX12

ATC

gabapentin; oral

1.4

42.3

1915

12015

R06AX27

ATC

desloratadine; oral

1.3

42.2

3697

25893

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

42.2

3832

26975

P01

ICPC

Feeling anxious/nervous/tense

1.4

42.2

1929

12124

R02

ICPC

Shortness of breath/dyspnoea

1.5

42.2

1725

10598

SPAT1283

SPAT

Restricted health certificate

1.3

42.1

3162

21646

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

42.0

1509

9016

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

41.9

1375

8049

ZXA10

NOMESCO Finland

Bilateral

1.4

41.7

2522

16671

J01FF01

ATC

clindamycin; systemic

1.3

41.2

4110

29300

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

41.0

2025

12910

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

40.8

1233

7074

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

40.7

1155

6524

L01

ICPC

Neck symptom/complaint

1.5

40.7

1763

10957

N02AX02

ATC

tramadol; systemic, rectal

1.2

40.6

6453

48672

P99

ICPC

Psychological disorders other

2.2

40.4

449

1849

R21

ICPC

Throat symptom/complaint

1.3

40.4

3449

24052

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

40.2

1013

5548

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

40.1

8523

66306

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

40.0

1674

10329

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

39.7

1674

10347

H062, E050

ICD-10 Finland

+∞

39.7

R55

ICD-10 Finland

Syncope and collapse

1.5

39.5

1689

10468

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.5

39.5

1629

10024

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

39.3

2846

19357

M79.1

ICD-10 Finland

Myalgia

1.5

39.2

1663

10292

C10AA01

ATC

simvastatin; oral

1.2

39.1

6573

49835

D07AC01

ATC

betamethasone; topical

1.3

39.0

5134

37854

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

38.9

1379

8210

C07AB02

ATC

metoprolol; systemic

1.3

38.8

3024

20793

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

38.6

8051

62418

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

38.6

6317

47738

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

6.9

38.5

100

128

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

38.5

1535

9377

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

38.5

997

5501

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

38.3

705

3518

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

38.3

985

5424

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.5

38.1

311

1100

E000001

ATC

1.3

38.1

3206

22289

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

38.0

2538

17035

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

37.9

4095

29446

L02BG04

ATC

letrozole; oral

2.1

37.9

463

1988

Z39.2

ICD-10 Finland

Routine postpartum follow-up

1.4

37.7

2389

15894

SPAT1197

SPAT

Extensive health check-up of expecting family

1.3

37.7

2740

18635

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

37.4

636

3093

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

37.2

1270

7497

J01FA09

ATC

clarithromycin; systemic

1.3

37.2

4281

31025

R05

ICPC

Cough

1.3

37.1

3176

22121

-50

ICPC

Medication/prescr/renewal

1.8

37.1

633

3080

R52.9

ICD-10 Finland

Pain, unspecified

1.6

36.9

1081

6154

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

36.9

916

4993

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

+∞

36.7

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

+∞

36.7

A02BC03

ATC

lansoprazole; oral

1.3

36.7

3803

27188

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

36.6

4863

35845

SPAT1211

SPAT

Application of soft bandage

1.5

36.5

1354

8140

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

36.5

2090

13669

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

36.4

748

3866

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

36.3

1275

7572

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

36.3

838

4480

N04BC05

ATC

pramipexole; oral

1.7

36.3

821

4364

F32

ICD-10 Finland

Depressive episode

1.7

36.1

771

4030

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

36.1

3039

21115

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

36.0

2256

14977

BA1AE

SPAT

5.8

36.0

106

161

B02AA02

ATC

tranexamic acid; systemic

1.6

36.0

1127

6521

D35.30

ICD-10 Finland

Craniopharyngoma

74.2

35.7

G03GA05

ATC

follitropin alfa; parenteral

2.1

35.7

412

1727

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

35.6

941

5220

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

35.6

1093

6295

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

35.1

199

560

P29

ICPC

Psychological sympt/compl other

1.6

35.1

934

5190

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

35.0

388

1597

WZA90

NOMESCO Finland

Other doctors statement

1.3

35.0

3645

26048

R60.0

ICD-10 Finland

Localized oedema

1.5

34.9

1374

8369

24110

ICD-8 Finland

Non-toxic nodular goitre, Sporadic

+∞

34.7

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.3

34.7

342

1334

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

34.6

4561

33552

SPAT1097

SPAT

Recording of ECG

1.4

34.5

2026

13299

N03AE01

ATC

clonazepam; systemic

1.7

34.5

725

3768

N05AF03

ATC

chlorprothixene; systemic

2.1

34.5

412

1751

A28

ICPC

Limited function/disability NOS

1.4

34.5

1940

12640

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

34.5

3177

22333

SPAT1380

SPAT

Postpartum check-up

1.4

34.3

2144

14224

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

315.6

34.2

E66

ICD-10 Finland

Obesity

1.9

34.1

512

2382

P06

ICPC

Sleep disturbance

1.5

34.1

1391

8531

N06AG02

ATC

moclobemide; oral

1.9

34.1

546

2602

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

34.1

5577

42014

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

34.1

632

3162

SPAT1229

SPAT

Assessment of need for aid

1.6

34.1

967

5460

M01AB05

ATC

diclofenac; systemic, rectal

1.2

34.0

10419

83447

E03.3

ICD-10 Finland

Postinfectious hypothyroidism

163.2

33.9

Z01.7

ICD-10 Finland

Laboratory examination

1.4

33.8

1541

9662

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

33.7

581

2838

J01FA06

ATC

roxithromycin; oral

1.2

33.5

5573

42038

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

33.5

535

2546

H3603, E103

ICD-10 Finland

2.9

33.5

209

630

C10AA05

ATC

atorvastatin; oral

1.2

33.4

5606

42328

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

33.3

2432

16528

Z00.0

ICD-10 Finland

General medical examination

1.3

33.3

2915

20343

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

33.2

4499

33170

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

33.2

758

4041

E22.1

ICD-10 Finland

Hyperprolactinaemia

3.9

33.1

141

318

R07.0

ICD-10 Finland

Pain in throat

1.6

33.0

896

5002

I47.2

ICD-10 Finland

Ventricular tachycardia

2.1

33.0

392

1665

2506

FHL

Thyroidectomy

158.8

32.9

WZC30

NOMESCO Finland

Teaching

1.4

32.8

1830

11901

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

32.8

321

1250

24209

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffuse NUD

+∞

32.7

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

19.6

32.7

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.2

32.6

330

1305

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.3

32.5

172

463

K90.0

ICD-10 Finland

Coeliac disease

2.1

32.5

398

1713

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

32.5

2114

14110

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.7

32.4

749

4007

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.2

32.2

327

1293

R06AE09

ATC

levocetirizine; oral

1.4

32.2

1865

12207

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.5

32.2

254

884

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

32.2

1115

6600

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

4.7

31.9

113

213

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

31.8

1181

7097

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

31.8

566

2794

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

31.8

575

2854

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.6

31.7

148

361

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.0

31.7

440

1990

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.6

31.7

245

844

J01MA02

ATC

ciprofloxacin; systemic

1.2

31.6

6174

47278

H01CC01

ATC

ganirelix; parenteral

2.3

31.6

311

1214

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.5

31.6

155

394

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

31.5

659

3424

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

31.5

1009

5865

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.2

31.5

333

1344

301

Kela drug reimbursment

Growth hormone

11.2

31.4

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.4

31.3

2076

13892

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.4

31.2

1529

9716

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.3

31.1

120

247

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

31.0

813

4499

H3601, E103

ICD-10 Finland

2.9

30.9

199

612

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

30.9

298

1152

SPAT1252

SPAT

Overall medication plan or its review

1.6

30.9

953

5492

N06AX22

ATC

agomelatine; oral

2.3

30.8

310

1223

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

30.8

3655

26498

E83.51

ICD-10 Finland

Hypocalcemia

4.9

30.6

104

188

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

30.5

383

1665

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.3

30.5

283

1072

SPAT1053

SPAT

Memory test

1.4

30.4

1963

13075

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.3

30.3

158

421

R03BA05

ATC

fluticasone; inhalant

1.3

30.3

2449

16878

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

30.2

800

4436

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.7

30.2

221

737

E07.89

ICD-10 Finland

Other specified disorders of thyroid

54.4

30.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

30.2

1425

8988

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

30.2

3956

29010

K04

ICPC

Palpitations/awareness of heart

1.8

30.2

591

3009

J01EA01

ATC

trimethoprim; systemic

1.3

30.1

2744

19230

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

30.0

1925

12807

T71

ICPC

Malignant neoplasm thyroid

100.0

30.0

R74

ICPC

Upper respiratory infection acute

1.2

29.9

4421

32853

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.4

29.9

255

926

XCK00

NOMESCO Finland

Perimetry

1.6

29.8

813

4543

-1

NOMESCO Finland

1.2

29.8

5508

41896

2451A

ICD-9 Finland

Thyroiditis, Subacute thyroiditis

+∞

29.8

SPAT1196

SPAT

Monitoring of normal pregnancy

1.5

29.7

1106

6647

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

29.7

1740

11404

107

Kela drug reimbursment

Pernicious anaemia

2.3

29.6

283

1090

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

29.6

3485

25233

WX402

NOMESCO Finland

General anaesthesia

1.3

29.5

2300

15764

E02

ICD-10 Finland

Subclinical iodine-deficiency hypothyroidism

32.1

29.5

A11CC02

ATC

dihydrotachysterol; oral

13.9

29.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

29.4

1415

8955

UKC02

NOMESCO Finland

Cystoscopy

1.3

29.4

2820

19892

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

29.4

971

5686

R05

ICD-10 Finland

Cough

1.3

29.4

2476

17159

R01AD01

ATC

beclometasone; nasal

1.4

29.3

1792

11828

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.0

29.3

375

1643

A01

ICPC

Pain general/multiple sites

1.5

29.2

904

5216

C10AA07

ATC

rosuvastatin; oral

1.3

29.2

3061

21841

M04AA01

ATC

allopurinol; systemic

1.3

29.1

2224

15196

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

29.1

1385

8747

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

29.1

2397

16558

N06AA09

ATC

amitriptyline; systemic

1.5

29.1

985

5800

R06AX22

ATC

ebastine; oral

1.3

29.1

1915

12794

Z2445

NOMESCO Finland

Psychologist

1.7

29.0

655

3479

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

9.6

29.0

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

29.0

2291

15730

C03DA01

ATC

spironolactone; oral

1.4

28.9

1482

9490

EBA00

NOMESCO Finland

Extraction of tooth

1.2

28.9

5745

43984

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

7.0

28.9

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

2.1

28.9

334

1405

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

28.8

3662

26735

SPAT1281

SPAT

Other administrative function

1.4

28.8

1241

7689

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

28.8

1321

8288

N02AA05

ATC

oxycodone; systemic

1.3

28.7

1972

13256

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

28.7

498

2439

R03DC03

ATC

montelukast; oral

1.4

28.7

1823

12104

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

28.7

1198

7380

E23.03

ICD-10 Finland

Lack of ACTH

11.9

28.6

TLW10

NOMESCO Finland

Transfer of fresh embryo

2.5

28.6

236

844

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.9

28.6

413

1898

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

28.6

888

5127

D11

ICPC

Diarrhoea

1.4

28.5

1637

10694

SPAT1139

SPAT

Nutrition survey

1.8

28.5

469

2258

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

28.4

1409

8965

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

28.3

1865

12461

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

7.3

28.2

D07AC13

ATC

mometasone; topical

1.2

28.1

4149

30792

O99.80

ICD-10 Finland

The fear of childbirth

1.6

28.1

730

4031

M79.7

ICD-10 Finland

Fibromyalgia

2.5

28.1

231

822

M01AH05

ATC

etoricoxib; oral

1.2

28.0

8204

65009

RD210

NOMESCO Finland

2.2

28.0

298

1208

N06AX03

ATC

mianserin; oral

1.7

28.0

564

2899

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

28.0

3390

24605

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

27.9

788

4443

A07AA02

ATC

nystatin; oral

1.7

27.9

667

3599

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

27.8

1270

7959

P20

ICPC

Memory disturbance

1.4

27.8

1452

9328

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

27.7

5616

43035

105

Kela drug reimbursment

Adrenal cortical hypofunction

9.3

27.6

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.8

27.6

534

2712

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

27.6

659

3558

N05AB03

ATC

perphenazine; systemic, rectal

1.8

27.5

463

2245

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

1.8

27.5

455

2196

207

Kela drug reimbursment

Chronic arrhythmias

1.3

27.3

2079

14194

E04

ICD-10 Finland

Other nontoxic goitre

13.1

27.2

G04CA02

ATC

tamsulosin; oral

1.2

27.1

5317

40594

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.7

27.1

611

3246

Z2446

NOMESCO Finland

Social worker

1.5

27.1

980

5858

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

27.0

1467

9484

J01MA12

ATC

levofloxacin; systemic

1.3

27.0

2784

19799

N05BE01

ATC

buspirone; oral

1.9

26.9

403

1875

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

7.2

26.9

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.8

26.9

180

570

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.6

26.8

733

4102

2448A

ICD-9 Finland

Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]

+∞

26.8

24200

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi

+∞

26.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

26.7

1101

6759

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

2.5

26.7

210

733

Z2221

NOMESCO Finland

Medical doctor

1.2

26.6

4135

30836

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

26.5

983

5909

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

26.5

1069

6539

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

26.2

1827

12308

N06BA04

ATC

methylphenidate; oral

1.9

26.2

389

1808

F61.0

ICD-10 Finland

Mixed personality disorders

2.3

26.1

259

1016

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

26.0

487

2446

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

3.5

26.0

128

328

T99

ICPC

Endocr/metab/nutrit disease other

2.5

26.0

208

732

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

25.9

887

5235

E05.5

ICD-10 Finland

Thyroid crisis or storm

+∞

25.8

2420A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic diffuse goitre

+∞

25.8

A03

ICPC

Fever

1.3

25.8

2609

18507

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

25.7

1319

8443

G03GA02

ATC

human menopausal gonadotrophin; parenteral

2.5

25.7

203

708

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.0

25.7

153

449

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

25.7

1069

6578

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

25.7

649

3559

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.3

25.7

2144

14824

C08CA01

ATC

amlodipine; oral

1.2

25.6

4930

37538

Z3226

NOMESCO Finland

Physiotherapist

1.3

25.6

2513

17756

S29

ICPC

Skin symptom/complaint other

1.3

25.6

2317

16199

SPAT1234

SPAT

Support of social functional capacity

1.6

25.5

656

3614

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

25.5

451

2225

N05CD07

ATC

temazepam; oral

1.4

25.4

1556

10262

T28

ICPC

Limited function/disability (T)

3.0

25.4

151

442

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

54.6

25.4

E23.08

ICD-10 Finland

Hypopituitarism

54.6

25.4

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

238.9

25.4

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.5

25.3

213

769

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

8.7

25.3

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

25.2

3127

22725

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

25.2

1043

6406

L15

ICPC

Knee symptom/complaint

1.3

25.2

2468

17429

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.0

25.1

323

1420

M54

ICD-10 Finland

Dorsalgia

1.4

25.0

1429

9318

N06AX05

ATC

trazodone; oral

2.1

25.0

305

1312

D01

ICPC

Abdominal pain/cramps general

1.4

25.0

1536

10137

B01AA03

ATC

warfarin; systemic

1.2

25.0

3238

23650

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.8

24.9

412

1989

24509

ICD-8 Finland

Thyroiditis, Unspecified

+∞

24.8

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.5

24.7

806

4709

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.0

24.6

144

419

A29

ICPC

General symptom/complaint other

1.4

24.6

1484

9766

K07.60

ICD-10 Finland

Snapping jaw

1.7

24.6

552

2931

A46

ICD-10 Finland

Erysipelas

1.3

24.5

2026

13981

T83

ICPC

Overweight

2.4

24.5

221

829

N04BC06

ATC

cabergoline; oral (dopamine agonists)

3.9

24.5

105

240

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

24.5

748

4301

K59.0

ICD-10 Finland

Constipation

1.6

24.5

708

4020

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

229.8

24.4

BAA99

NOMESCO Finland

Other operation on thyroid gland

229.8

24.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

24.4

1573

10462

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

24.3

895

5368

XKD00

NOMESCO Finland

Uroflowmetry

1.2

24.3

3376

24844

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

24.3

478

2439

A10AB06

ATC

insulin glulisine; parenteral

2.6

24.3

187

643

J45

ICD-10 Finland

Asthma

1.4

24.2

1079

6727

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

24.1

2607

18631

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.9

24.1

383

1823

N17

ICPC

Vertigo/dizziness

1.4

24.1

1304

8428

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.3

24.0

1592

10640

TLW12

NOMESCO Finland

Insertion of frozen embryo

2.3

23.9

236

927

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.1

23.8

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.0

23.8

316

1408

R06AX13

ATC

loratadine; oral

1.3

23.8

1917

13184

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.8

23.8

441

2210

P74

ICPC

Anxiety disorder/anxiety state

1.6

23.8

587

3201

XF404

NOMESCO Finland

Ambulatory ECG

1.4

23.7

1282

8281

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

23.7

263

1088

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

23.7

668

3770

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

1.5

23.6

761

4431

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

23.6

1777

12101

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

23.5

596

3269

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

23.5

752

4370

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.8

23.5

101

232

N97.8

ICD-10 Finland

Female infertility of other origin

2.1

23.5

259

1070

C09AA05

ATC

ramipril; oral

1.2

23.5

3662

27273

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

220.6

23.4

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

23.4

725

4184

UDC00

NOMESCO Finland

Ear microscopy

1.4

23.4

1041

6492

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

23.4

1151

7314

A99

ICPC

Disease/condition unspecnature/site

1.4

23.3

1028

6398

A06AC51

ATC

ispaghula, combinations; systemic

1.7

23.2

539

2890

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

23.2

401

1967

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

3.4

23.2

116

302

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.3

23.1

226

884

L02

ICPC

Back symptom/complaint

1.4

23.1

1132

7187

N05AE04

ATC

ziprasidone; systemic

3.2

23.1

123

336

K30

ICD-10 Finland

Functional dyspepsia

1.4

23.1

1122

7112

S06.0

ICD-10 Finland

Concussion

1.3

23.0

1501

9996

J05AB01

ATC

aciclovir; systemic

1.3

23.0

2499

17864

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.5

23.0

871

5259

D06

ICPC

Abdominal pain localized other

1.4

22.9

1071

6738

N30.0

ICD-10 Finland

Acute cystitis

1.3

22.9

1486

9893

SPAT1255

SPAT

Intravenous administration of medicine

1.5

22.9

930

5693

N03AX11

ATC

topiramate; oral

2.0

22.9

282

1221

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

22.8

5749

44753

N06AA06

ATC

trimipramine; systemic

2.0

22.8

286

1244

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

+∞

22.8

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

22.8

380

1839

N01

ICPC

Headache

1.3

22.8

1608

10846

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.4

22.8

1365

8974

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

22.8

2403

17118

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

7.3

22.7

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

22.7

479

2497

A10BH01

ATC

sitagliptin; oral

1.4

22.7

1281

8335

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

22.7

1959

13599

T81

ICPC

Goitre

13.6

22.6

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

22.6

3444

25572

MAA00

NOMESCO Finland

Amniocentesis

2.5

22.5

189

682

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.3

22.5

1742

11904

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

22.5

942

5801

C09CA06

ATC

candesartan; oral

1.3

22.4

2521

18094

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

110.2

22.3

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

22.3

1128

7199

L12

ICPC

Hand/finger symptom/complaint

1.3

22.3

1824

12565

J20

ICD-10 Finland

Acute bronchitis

1.4

22.3

1119

7135

M01AC06

ATC

meloxicam; systemic, rectal

1.2

22.2

4237

32157

SPAT1243

SPAT

Psychiatric/psychological examination

1.7

22.2

479

2515

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.1

22.2

261

1109

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

12.1

22.0

L16

ICPC

Ankle symptom/complaint

1.4

22.0

1276

8339

R09

ICPC

Sinus symptom/complaint

1.5

22.0

899

5511

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

21.9

1084

6891

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

21.9

2751

19995

R03BA02

ATC

budesonide; inhalant

1.3

21.9

2197

15545

G03HB01

ATC

cyproterone and estrogen; systemic

1.4

21.9

1063

6735

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

21.9

952

5907

F40.1

ICD-10 Finland

Social phobias

1.8

21.9

395

1966

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

21.9

3427

25509

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.6

21.8

100

243

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

21.8

1153

7416

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.9

21.8

325

1515

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

21.8

370

1805

L14

ICPC

Leg/thigh symptom/complaint

1.5

21.8

870

5309

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.0

21.7

275

1204

ZX120

NOMESCO Finland

Intravenous

1.4

21.7

1228

7996

-60

ICPC

Result test/procedure

1.5

21.6

758

4501

TLW00

NOMESCO Finland

Insemination

2.0

21.6

279

1233

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.3

21.5

2273

16185

H01CA02

ATC

nafarelin; nasal

2.3

21.5

198

752

SPAT1104

SPAT

Monitoring of emergency patient

1.5

21.5

895

5506

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

21.5

584

3265

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

21.5

2219

15758

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

21.5

2364

16919

A02BC04

ATC

rabeprazole; oral

1.5

21.5

879

5391

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

21.4

782

4680

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

73.5

21.4

G01AA10

ATC

clindamycin; vaginal

1.5

21.4

692

4036

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

21.3

2116

14956

H02AB07

ATC

prednisone; oral

1.3

21.2

1719

11822

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.6

21.2

503

2714

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

21.2

1197

7789

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

21.2

2701

19663

K78

ICPC

Atrial fibrillation/flutter

1.4

21.1

1070

6830

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

21.1

1338

8871

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.3

21.1

206

806

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.5

21.1

171

609

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

21.1

885

5456

D07AA02

ATC

hydrocortisone; topical

1.3

21.0

2053

14471

SPAT1357

SPAT

Monitoring of problem during pregnancy

1.7

21.0

411

2098

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

20.9

783

4714

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

20.9

284

1278

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

+∞

20.8

2448X

ICD-9 Finland

Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS ACQUISATA ALIA]

+∞

20.8

24599

ICD-8 Finland

Thyroiditis, Unspecified

+∞

20.8

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

20.8

2298

16450

K04.0

ICD-10 Finland

Pulpitis

1.3

20.8

1366

9109

E06

ICD-10 Finland

Thyroiditis

24.0

20.7

R06.5

ICD-10 Finland

Mouth breathing

1.4

20.7

1249

8218

-34

ICPC

Blood test

1.7

20.7

409

2095

G02CB01

ATC

bromocriptine; systemic

3.2

20.5

113

317

D07AD01

ATC

clobetasol; topical

1.3

20.5

1760

12197

Q90.9

ICD-10 Finland

Down syndrome, unspecified

18.8

20.5

SPAT1058

SPAT

PEF monitoring instruction

1.4

20.5

1005

6381

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

20.5

3686

27799

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

20.4

1176

7674

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

101.4

20.4

-31

ICPC

Medical examin/health eval partial

1.4

20.4

988

6258

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.0

20.4

118

343

H05.2

ICD-10 Finland

Exophthalmic conditions

7.2

20.3

N06AA12

ATC

doxepin; systemic

1.6

20.3

563

3164

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

20.2

815

4984

F99

ICD-10 Finland

Mental disorder, not otherwise specified

1.9

20.2

281

1279

EMB10

NOMESCO Finland

Tonsillectomy

1.4

20.1

944

5949

A02BA02

ATC

ranitidine; systemic

1.2

20.0

2409

17415

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

19.9

409

2120

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

19.9

669

3937

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

19.9

483

2623

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

19.9

807

4942

W85

ICPC

Gestational diabetes

1.5

19.9

685

4053

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.2

19.9

206

830

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

19.9

356

1767

O992, E039

ICD-10 Finland

+∞

19.8

24100

ICD-8 Finland

Non-toxic nodular goitre, Endemic

+∞

19.8

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

19.8

3079

22884

N06AB08

ATC

fluvoxamine; oral

1.9

19.7

291

1351

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

19.7

1599

11000

L29

ICPC

Musculoskeletal sympt/complt other

1.4

19.6

852

5287

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

19.6

801

4911

A01AB09

ATC

miconazole; local oral

1.4

19.6

884

5526

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

19.6

802

4919

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.0

19.6

270

1224

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

19.6

2634

19272

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.0

19.6

116

343

C09CA01

ATC

losartan; oral

1.2

19.5

2948

21834

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.2

19.5

202

812

A08

ICPC

Swelling

1.7

19.4

437

2327

AA400

NOMESCO Finland

Electroconvulsive therapy

2.7

19.4

132

426

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

19.4

1047

6760

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

19.4

661

3900

U02

ICPC

Urinary frequency/urgency

1.3

19.4

1366

9207

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

19.4

350

1744

R03BA08

ATC

ciclesonide; inhalant

1.4

19.3

854

5319

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

5.7

19.3

JN4BD

NOMESCO Finland

Extensive body CT

1.3

19.3

1443

9810

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

19.3

2779

20483

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

19.3

440

2350

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

19.2

763

4651

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.8

19.2

330

1616

XQ800

NOMESCO Finland

Prick test

1.4

19.2

870

5444

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

19.1

735

4453

M02AA07

ATC

piroxicam; topical

1.2

19.1

4402

33922

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

19.1

739

4484

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.7

19.0

418

2210

HMAK

NOMESCO Finland

1.3

19.0

1705

11883

E23.2

ICD-10 Finland

Diabetes insipidus

6.2

19.0

A10BK03

ATC

empagliflozin; oral

1.4

19.0

907

5731

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

19.0

576

3311

M02AA10

ATC

ketoprofen; topical

1.3

19.0

1744

12198

C05AA08

ATC

fluocortolone; rectal, topical

1.3

18.9

1665

11576

N03AF02

ATC

oxcarbazepine; oral

1.7

18.9

427

2275

D12

ICPC

Constipation

1.7

18.9

418

2214

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.2

18.9

2338

16946

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.4

18.8

1067

6947

24099

ICD-8 Finland

Simple goitre, Unspecified

+∞

18.8

24500

ICD-8 Finland

Thyroiditis, Subacuta de Quervain

+∞

18.8

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

2.9

18.7

116

354

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

18.7

1939

13766

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

18.7

423

2255

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

18.7

1837

12955

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

18.6

2547

18662

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.6

18.6

136

459

A10BH05

ATC

linagliptin; oral

1.5

18.6

613

3592

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

18.6

685

4113

SPAT1285

SPAT

Provision of consultation response

1.5

18.6

714

4327

J01FA01

ATC

erythromycin; systemic

1.3

18.5

1985

14147

WX723

NOMESCO Finland

CPAP therapy

1.6

18.5

444

2407

H53.2

ICD-10 Finland

Diplopia

1.7

18.5

376

1946

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

3.9

18.4

170

H92.0

ICD-10 Finland

Otalgia

1.5

18.4

579

3358

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

18.3

1673

11687

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

18.3

1186

7888

SPAT1192

SPAT

Gynaecological examination

1.3

18.3

1541

10651

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

18.3

970

6247

L08

ICPC

Shoulder symptom/complaint

1.2

18.3

2206

15946

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.9

18.2

287

1365

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

18.2

312

1528

ZXA05

NOMESCO Finland

Left side

1.2

18.2

3252

24471

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

18.2

989

6393

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

18.2

883

5595

R07

ICPC

Sneezing/nasal congestion

1.4

18.1

928

5941

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

18.1

169

649

F93.89

ICD-10 Finland

Other childhood emotional disorders

2.2

18.0

187

752

WX320

NOMESCO Finland

Spinalanesthesy

1.2

18.0

3057

22899

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.4

18.0

155

573

DQE00

NOMESCO Finland

Implantation of prosthetic replacement for larynx

7.4

17.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

17.9

2913

21726

H36.01

ICD-10 Finland

Diabetic maculopathy

2.1

17.9

194

799

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

17.9

1136

7536

D10

ICPC

Vomiting

1.4

17.9

922

5908

UJC01

NOMESCO Finland

Scopy of lower throat

2.4

17.9

154

569

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.3

17.9

252

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.4

17.8

901

5753

J46

ICD-10 Finland

Status asthmaticus

1.9

17.8

262

1219

L01XE04

ATC

[U] sunitinib; oral

4.6

17.8

118

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.3

17.8

170

661

N05AH02

ATC

clozapine; systemic

1.9

17.7

277

1317

B01AF02

ATC

apixaban; oral

1.3

17.7

1187

7939

A10BJ02

ATC

liraglutide; parenteral

1.9

17.7

269

1268

SPAT1324

SPAT

Screening procedure

1.3

17.6

1124

7460

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

17.6

1892

13489

C739

ICD-10 Finland

167.5

17.6

H03AA02

ATC

liothyronine sodium; systemic

167.5

17.6

S76

ICPC

Skin infection other

1.5

17.5

640

3835

C08CA13

ATC

lercanidipine; oral

1.3

17.5

1441

9927

D07AB08

ATC

desonide; topical

1.3

17.5

1427

9816

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

17.5

1063

6999

L60.0

ICD-10 Finland

Ingrowing nail

1.5

17.5

538

3105

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

17.5

782

4883

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

17.5

499

2830

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

17.5

1245

8405

K80

ICPC

Cardiac arrhythmia NOS

1.4

17.4

780

4871

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

17.4

3341

25300

Y28

ICPC

Limited function/disability (Y)

3.1

17.4

276

20199

ICD-8 Finland

Hodgkin's disease

13.0

17.4

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

17.4

810

5095

E20.8

ICD-10 Finland

Other hypoparathyroidism

33.8

17.4

C10AX09

ATC

ezetimibe; oral

1.3

17.3

1376

9433

K07

ICPC

Swollen ankles/oedema

1.6

17.3

440

2422

A10BJ06

ATC

semaglutide; parenteral

1.7

17.3

358

1862

H01

ICPC

Ear pain/earache

1.3

17.3

1442

9951

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

17.3

2394

17555

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

15.0

17.3

D19

ICPC

Teeth/gum symptom/complaint

1.2

17.3

3654

27911

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

17.3

844

5358

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

17.3

4873

38118

DQB30

NOMESCO Finland

Laryngectomy

7.3

17.2

W92

ICPC

Compl labour/ delivery livebirth

1.7

17.2

388

2068

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

17.2

288

1402

R03AC03

ATC

terbutaline; inhalant

1.3

17.2

1624

11393

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

17.2

372

1958

197

Kela drug reimbursment

Sunitinib

4.0

17.2

151

C02AC05

ATC

moxonidine; oral

1.5

17.2

563

3299

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

4.5

17.1

119

R96

ICPC

Asthma

1.4

17.1

933

6037

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

17.1

1227

8293

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

17.1

5131

40327

R4190

NOMESCO Finland

Nutritional therapy

1.6

17.1

447

2481

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.4

17.1

783

4914

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

9.6

17.0

CKC12

NOMESCO Finland

Photocoagulation of retina

1.5

17.0

546

3179

R52.2

ICD-10 Finland

Other chronic pain

1.7

17.0

341

1756

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

17.0

836

5309

H13

ICPC

Plugged feeling ear

1.2

17.0

2503

18475

B01AB10

ATC

tinzaparin; parenteral

1.4

17.0

772

4834

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.6

17.0

128

440

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

16.9

5526

43687

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.0

16.9

214

941

JN5SN

NOMESCO Finland

+∞

16.9

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

16.8

674

4118

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

16.8

708

4371

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

16.8

397

2147

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.9

16.7

247

1152

S97

ICPC

Chronic ulcer skin

1.4

16.7

691

4252

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

16.7

1267

8629

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

16.7

1147

7700

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

1.7

16.6

320

1630

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.4

16.6

859

5504

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

16.6

5125

40340

A05

ICPC

Feeling ill

1.4

16.5

957

6254

F41.00

ICD-10 Finland

Moderate panic disorder

1.9

16.5

235

1082

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

16.5

826

5265

M48.0

ICD-10 Finland

Spinal stenosis

1.3

16.5

1352

9306

Z51.88

ICD-10 Finland

Other specified medical care

1.9

16.5

239

1108

C01DA14

ATC

isosorbide mononitrate; oral

1.2

16.5

2344

17237

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

16.5

276

1346

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.0

16.4

296

N76.0

ICD-10 Finland

Acute vaginitis

1.4

16.4

743

4651

C08CA02

ATC

felodipine; oral

1.3

16.4

1187

8033

D02AE01

ATC

carbamide; topical

1.4

16.3

844

5410

R01AD11

ATC

triamcinolone; nasal

1.4

16.3

951

6223

A97

ICPC

No disease

1.2

16.3

2224

16279

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

16.3

461

2611

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

16.3

617

3731

KGH10

NOMESCO Finland

Operation for phimosis

1.5

16.3

487

2793

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

16.3

751

4716

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

16.3

1827

13091

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.7

16.3

332

1721

N19

ICD-10 Finland

Unspecified kidney failure

1.6

16.2

455

2568

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

16.2

765

4825

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.3

16.2

1412

9802

O90.5

ICD-10 Finland

Postpartum thyroiditis

21.2

16.1

N03AX14

ATC

levetiracetam; systemic

1.7

16.1

338

1767

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.3

16.1

224

R35

ICD-10 Finland

Polyuria

1.4

16.1

931

6087

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.5

16.0

197

N97.4

ICD-10 Finland

Female infertility associated with male factors

2.0

16.0

209

930

I50

ICD-10 Finland

Heart failure

1.7

15.9

365

1956

N05AF01

ATC

flupentixol; systemic

2.2

15.9

170

697

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.4

15.9

786

4999

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

15.9

2219

16281

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.7

15.9

337

1766

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

9.4

15.9

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

15.8

434

2439

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

55.8

15.8

JN4AD

NOMESCO Finland

Body CT examination

1.3

15.8

975

6439

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

15.7

553

3289

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

15.7

448

2543

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

15.7

777

4945

22620

ICD-8 Finland

Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)

149.8

15.6

R06AX26

ATC

fexofenadine; oral

1.4

15.6

667

4129

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

2.9

15.6

298

N06AX18

ATC

reboxetine; oral

2.6

15.6

119

411

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.5

15.6

576

3463

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.5

15.6

120

419

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

15.6

4035

31317

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

15.6

1367

9501

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

15.5

530

3135

E29.1

ICD-10 Finland

Testicular hypofunction

2.0

15.5

197

867

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

15.5

825

5317

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

15.5

425

2387

S21

ICPC

Skin texture symptom/complaint

1.3

15.5

1631

11596

L50.3

ICD-10 Finland

Dermatographic urticaria

2.1

15.5

174

730

A55

ICPC

General and Unspecified, Local injection/infiltration

2.4

15.4

137

515

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.4

15.4

689

4303

SPAT1360

SPAT

Extensive global examination

1.4

15.4

941

6209

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

15.3

653

4043

C10AA03

ATC

pravastatin; oral

1.4

15.3

834

5395

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

15.3

243

1165

WX002

NOMESCO Finland

Sedation and analgesia

1.2

15.3

2478

18453

R12

ICD-10 Finland

Heartburn

1.4

15.3

777

4969

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.9

15.3

239

1140

M10.9

ICD-10 Finland

Gout, unspecified

1.3

15.3

1033

6918

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

3.2

15.2

229

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

15.2

413

2314

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

15.2

507

2983

K08.3

ICD-10 Finland

Retained dental root

1.4

15.2

911

5988

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

15.2

863

5621

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

15.2

257

1258

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

15.2

856

5574

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

15.1

569

3436

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

15.1

151

601

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.2

15.0

2040

14920

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

15.0

819

5298

Z00.8

ICD-10 Finland

Other general examinations

1.3

15.0

980

6530

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.7

15.0

318

1667

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

21.5

14.9

S01GX02

ATC

levocabastine; ophthalmic

1.4

14.9

636

3936

R04.2

ICD-10 Finland

Haemoptysis

1.5

14.9

488

2862

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.4

14.9

654

4071

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

14.9

1215

8362

E03.4

ICD-10 Finland

Atrophy of thyroid (acquired)

+∞

14.9

E23.0

ICD-10 Finland

Hypopituitarism

18.4

14.8

SPAT1251

SPAT

Organisation of medication

1.5

14.8

475

2769

ZXC86

NOMESCO Finland

Use of endoscopic device

2.9

14.8

271

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

4.9

14.8

TK800

NOMESCO Finland

Hemodialysis

1.7

14.8

323

1707

XF402

NOMESCO Finland

ECG with work load test

1.3

14.8

1420

9980

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.7

14.8

290

1488

A60

ICPC

General and Unspecified, Result test/procedure

1.5

14.8

513

3047

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

14.7

1077

7298

TAB00

NOMESCO Finland

Lumbar puncture

1.5

14.7

521

3107

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

14.7

572

3479

ZXA00

NOMESCO Finland

Right side

1.2

14.7

3414

26252

N03AF01

ATC

carbamazepine; oral, rectal

1.4

14.7

596

3658

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

14.7

2917

22136

S22

ICPC

Nail symptom/complaint

1.4

14.7

709

4495

G04CA01

ATC

alfuzosin; oral

1.2

14.6

2496

18673

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.5

14.6

451

2609

L84

ICPC

Back syndrome without radiat pain

1.5

14.6

478

2802

ZY000

NOMESCO Finland

Hospital inpatient

2.0

14.6

183

804

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

4.6

14.5

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

14.4

979

6564

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

3.4

14.4

177

R49.01

ICD-10 Finland

Functional dysphonia

1.8

14.4

250

1234

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

14.4

1797

13025

N07CA01

ATC

betahistine; oral

1.4

14.4

762

4910

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

14.3

659

4137

U04

ICPC

Incontinence urine

1.6

14.3

417

2377

N06AA04

ATC

clomipramine; systemic

2.0

14.3

179

784

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

14.3

583

3577

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

14.3

484

2858

LA2AE

NOMESCO Finland

Ultrasound examination of ovarian cyst

1.7

14.3

275

1402

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

14.3

1649

11845

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.3

14.3

952

6365

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

1.7

14.2

309

1631

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

1.9

14.2

206

956

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.3

14.2

133

515

RS220

NOMESCO Finland

2.0

14.2

185

825

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

14.2

411

2342

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.2

14.2

143

573

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

14.1

501

2988

E23.6

ICD-10 Finland

Other disorders of pituitary gland

13.0

14.1

C07AA07

ATC

sotalol; systemic

1.5

14.1

530

3201

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

4.3

14.1

106

K08.80

ICD-10 Finland

Toothache NOS

1.3

14.1

899

5971

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

14.0

352

1937

A12AA04

ATC

calcium carbonate; oral

1.8

14.0

224

1077

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

14.0

3543

27417

N05AL01

ATC

sulpiride; systemic

2.1

14.0

165

707

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

3.2

14.0

210

-48

ICPC

Clarification/discussion RFE/demand

1.5

14.0

430

2488

N04AA02

ATC

biperiden; systemic

1.8

13.9

242

1196

R07.3

ICD-10 Finland

Other chest pain

1.3

13.9

1075

7343

24400

ICD-8 Finland

Myxoedema, (hypothyreosis) post therapiam

+∞

13.9

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

13.9

207

971

I50.0

ICD-10 Finland

Congestive heart failure

1.3

13.9

1003

6784

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.8

13.9

234

1144

R03BA01

ATC

beclometasone; inhalant

1.2

13.9

1590

11416

E83.50

ICD-10 Finland

Hypercalcemia

2.4

13.8

116

426

SPAT1200

SPAT

Guidance for breast-feeding and breast care

1.5

13.8

475

2817

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

2.0

13.8

181

810

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.6

13.7

334

1822

L13

ICPC

Hip symptom/complaint

1.3

13.7

1441

10238

D07XC01

ATC

betamethasone, combinations; topical

1.2

13.7

1600

11508

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

13.7

3135

24059

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.4

13.7

679

4325

M54.2

ICD-10 Finland

Cervicalgia

1.4

13.7

748

4845

C01CA24

ATC

epinephrine; parenteral

1.4

13.7

665

4223

TFP35

NOMESCO Finland

Electroanatomical mapping

2.0

13.6

184

832

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

1.6

13.6

399

2282

J01

ICD-10 Finland

Acute sinusitis

1.5

13.6

485

2902

A91

ICPC

Abnormal result investigation NOS

1.5

13.5

471

2799

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

13.5

356

1984

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

13.5

1728

12560

SPAT1210

SPAT

Application of cast or individual aid

1.5

13.5

415

2402

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

13.5

1363

9642

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

2.7

13.4

295

G43.8

ICD-10 Finland

Other migraine

2.1

13.4

154

653

160

Kela drug reimbursment

exenatide

1.8

13.4

230

1131

F32.8

ICD-10 Finland

Other depressive episodes

1.9

13.4

197

919

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.4

13.4

565

3495

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.7

13.4

270

1399

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

13.4

292

1547

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

13.4

3738

29142

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.2

13.3

131

517

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.3

13.3

1303

9177

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

2.4

13.3

114

421

R06.4

ICD-10 Finland

Hyperventilation

1.9

13.3

206

979

J01MA06

ATC

norfloxacin; oral

1.3

13.3

1166

8102

SPAT1238

SPAT

Brief therapy

1.7

13.3

263

1354

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.4

13.3

773

5062

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.4

13.2

540

3319

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

13.2

897

6015

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.1

13.2

143

591

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

13.2

312

1688

C10AB05

ATC

fenofibrate; oral

1.8

13.2

230

1139

I95.1

ICD-10 Finland

Orthostatic hypotension

1.5

13.2

419

2440

H02AB04

ATC

methylprednisolone; systemic

1.2

13.2

1575

11362

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.6

13.1

313

1698

O60

ICD-10 Finland

Preterm labour and delivery

1.7

13.1

246

1246

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.2

13.1

1534

11038

L50.9

ICD-10 Finland

Urticaria, unspecified

1.5

13.1

403

2332

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.4

13.1

569

3539

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

13.1

675

4332

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.6

13.1

299

1605

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.5

13.1

398

2298

R04

ICPC

Breathing problem other

1.5

13.1

395

2278

ULA02

NOMESCO Finland

Kolposcopy

1.4

13.0

672

4311

B82

ICPC

Anaemia other/unspecified

1.7

13.0

297

1593

D07BC01

ATC

betamethasone and antiseptics; topical

1.2

13.0

1530

11012

G03GA06

ATC

follitropin beta; parenteral

2.4

13.0

107

389

AN1

Coronary angiography

1.2

13.0

1759

12856

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.7

13.0

273

1430

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

1.5

13.0

402

2330

SPAT1237

SPAT

Psychotherapy

2.5

13.0

106

382

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

13.0

1627

11792

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.4

13.0

671

4308

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

12.7

12.9

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.6

12.9

296

1589

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

12.9

3668

28618

N05AA01

ATC

chlorpromazine; systemic, rectal

2.0

12.9

168

750

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

12.9

465

2788

E06.5

ICD-10 Finland

Other chronic thyroiditis

+∞

12.9

2459X

ICD-9 Finland

Thyroiditis, unspecified

+∞

12.9

C09DX04

ATC

valsartan and sacubitril; oral

2.2

12.9

133

538

O02.1

ICD-10 Finland

Missed abortion

1.5

12.8

436

2577

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

1.8

12.8

202

966

J01MA14

ATC

moxifloxacin; systemic

1.3

12.8

1089

7534

R04.0

ICD-10 Finland

Epistaxis

1.3

12.8

956

6500

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

12.8

565

3527

2532A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]

123.4

12.7

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

4.0

12.7

109

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

12.7

461

2769

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.9

12.7

181

837

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.6

12.6

350

1977

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

12.6

1357

9668

EP1AE

SPAT

2.1

12.6

139

581

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

2.0

12.6

170

770

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

3.0

12.6

210

H60

ICD-10 Finland

Otitis externa

1.4

12.6

554

3456

P80

ICPC

Personality disorder

2.9

12.6

234

N05AH05

ATC

asenapine; oral

4.7

12.6

SPAT1101

SPAT

Orthostatic test

1.5

12.6

465

2800

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.3

12.6

1309

9292

H57.1

ICD-10 Finland

Ocular pain

1.6

12.6

322

1785

GD1AD

NOMESCO Finland

Thorax CT examination

1.4

12.5

528

3267

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

12.5

1051

7258

D09

ICPC

Nausea

1.4

12.5

610

3877

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

1.9

12.5

192

913

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.6

12.5

313

1722

SPAT1266

SPAT

Separate instruction to prepare for procedure

1.6

12.5

321

1777

159

Kela drug reimbursment

Pazopanib

5.0

12.5

GB1AA

NOMESCO Finland

Tracheal X-ray examination

22.7

12.5

HA1AA

NOMESCO Finland

X-ray mammography

2.1

12.5

140

589

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.3

12.5

822

5489

N02CC04

ATC

rizatriptan; oral

1.5

12.4

452

2714

E000006

ATC

1.4

12.4

691

4489

E000002

ATC

1.2

12.4

1511

10919

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

12.4

1542

11170

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

12.4

1173

8232

P73

ICPC

Affective psychosis

3.0

12.3

203

H53.4

ICD-10 Finland

Visual field defects

1.7

12.3

254

1325

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.4

12.3

673

4364

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

12.3

1613

11752

E000003

ATC

1.4

12.3

541

3375

SPAT1193

SPAT

Pap smear

1.3

12.3

1017

7015

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.5

12.2

361

2070

TFP34

NOMESCO Finland

Electrophysiological investigation

1.5

12.2

367

2111

205

Kela drug reimbursment

Chronic hypertension

1.1

12.2

4007

31576

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

12.2

1811

13359

N05AE05

ATC

lurasidone; oral

3.3

12.2

168

U71

ICPC

Cystitis/urinary infection other

1.5

12.2

473

2880

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.2

12.2

121

484

H25.8

ICD-10 Finland

Other senile cataract

1.3

12.2

1142

8003

K03.66

ICD-10 Finland

Tooth plaque

1.3

12.2

787

5241

L18

ICPC

Muscle pain

1.5

12.2

410

2424

K04.08

ICD-10 Finland

Other specified pulpit

1.3

12.2

831

5580

WW200

NOMESCO Finland

Immunization

1.5

12.1

358

2052

A27

ICPC

Fear of other disease NOS

1.4

12.1

485

2970

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.7

12.1

247

1286

C73.93

ICD-10 Finland

Anaplastic thyroid carcinoma (thyroid)

44.0

12.1

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

1.8

12.1

207

1019

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.8

12.1

220

1106

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.4

12.1

625

4015

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

12.1

648

4190

U07

ICPC

Urine symptom/complaint other

1.4

12.1

622

3991

F60.5

ICD-10 Finland

Anankastic personality disorder

2.1

12.1

132

549

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

4.6

12.0

T78.4

ICD-10 Finland

Allergy, unspecified

1.4

12.0

508

3143

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.5

12.0

360

2073

-44

ICPC

Preventive immunization/medic

1.3

12.0

1050

7294

2429X

ICD-9 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause

19.8

12.0

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

1.8

12.0

193

932

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

2.3

12.0

111

428

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.4

12.0

566

3577

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

11.9

714

4696

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.3

11.9

863

5842

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

11.9

1749

12888

L86

ICPC

Back syndrome with radiating pain

1.4

11.9

561

3545

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

+∞

11.9

Z31.5

ICD-10 Finland

Genetic counselling

1.4

11.9

485

2983

SPAT1377

SPAT

Polysomnography

1.5

11.9

372

2164

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.3

11.9

821

5524

S10

ICPC

Boil/carbuncle

1.4

11.8

686

4490

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

11.8

585

3728

WX892

NOMESCO Finland

Monitored bed care

1.3

11.8

1038

7212

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

2.3

11.8

105

398

L01XE11

ATC

[U] pazopanib; oral

5.8

11.8

WA039

NOMESCO Finland

Radiotherapy with free isotopes

114.6

11.8

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

11.8

1197

8472

MAC96

NOMESCO Finland

Other induction or advancement of labour

1.7

11.8

256

1358

3012

Kela drug reimbursment

Cabozantinib

4.6

11.8

QX3LT

NOMESCO Finland

Subcutaneous sclerotherapy

8.2

11.8

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2.4

11.8

358

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

12.3

11.7

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

6.0

11.7

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

11.7

700

4603

L11

ICPC

Wrist symptom/complaint

1.3

11.7

857

5811

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

10.1

11.7

WX722

NOMESCO Finland

PEEP

1.4

11.7

633

4095

P28

ICPC

Limited function/disability (P)

2.3

11.7

110

429

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

11.7

464

2836

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

11.7

910

6226

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

11.7

715

4723

N30

ICD-10 Finland

Cystitis

1.4

11.7

666

4351

O61.0

ICD-10 Finland

Failed medical induction of labour

2.2

11.7

117

469

SPAT1043

SPAT

Audiometry

1.3

11.7

1226

8714

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

11.7

608

3913

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.7

11.7

229

1181

Z50.5

ICD-10 Finland

Speech therapy

2.0

11.6

145

637

S06

ICPC

Rash localized

1.4

11.6

640

4156

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

11.6

809

5447

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

11.6

286

1569

Z96.4

ICD-10 Finland

Presence of endocrine implants

3.9

11.6

106

171

Kela drug reimbursment

Degludekinsuliini

3.3

11.6

151

H47.2

ICD-10 Finland

Optic atrophy

3.2

11.6

170

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

11.6

551

3488

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.4

11.6

687

4515

N97

ICD-10 Finland

Female infertility

2.3

11.6

104

398

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

2.6

11.5

293

O42.9

ICD-10 Finland

Premature rupture of membranes, unspecified

1.5

11.5

401

2389

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.7

11.5

219

1119

I50.1

ICD-10 Finland

Left ventricular failure

1.3

11.5

687

4521

T29

ICPC

Endocr/metab/nutr sympt/compl other

1.8

11.5

204

1021

H02AA02

ATC

fludrocortisone; oral

2.3

11.5

105

404

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

11.5

1275

9123

A10AA03

ATC

2.1

11.4

130

550

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.6

11.4

261

1404

L20.0

ICD-10 Finland

Besnier prurigo

1.3

11.4

919

6316

C03AA03

ATC

hydrochlorothiazide; oral

1.3

11.4

979

6783

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.4

11.4

551

3497

P85

ICPC

Mental retardation

4.7

11.4

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.5

11.4

342

1972

C09AA02

ATC

enalapril; systemic

1.2

11.3

2737

21074

S04

ICPC

Lump/swelling localized

1.3

11.3

1173

8323

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.3

11.3

105

408

XMA22

NOMESCO Finland

General examination of pregnant woman

1.4

11.3

449

2748

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.0

11.3

145

646

F33

ICD-10 Finland

Recurrent depressive disorder

1.7

11.3

222

1144

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.5

11.3

444

2711

H01CC02

ATC

cetrorelix; parenteral

3.5

11.2

127

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

3.9

11.2

105

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.1

11.2

133

573

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

3.4

11.2

141

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

2.5

11.2

296

R49.09

ICD-10 Finland

Unspecified dysphonia

2.2

11.2

107

422

Q90

ICD-10 Finland

Down syndrome

41.1

11.2

2542

FHL

Transasal hypophysectomy

18.7

11.2

D02

ICPC

Abdominal pain epigastric

1.4

11.2

607

3933

H26.4

ICD-10 Finland

After-cataract

1.3

11.1

803

5435

J04.0

ICD-10 Finland

Acute laryngitis

1.5

11.1

333

1920

1502

Kela drug reimbursment

Cabozantinib

4.4

11.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

11.1

834

5679

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.3

11.1

858

5865

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.9

11.1

164

773

O81.4

ICD-10 Finland

Vacuum extractor delivery

1.4

11.1

611

3972

Z39.1

ICD-10 Finland

Care and examination of lactating mother

1.6

11.0

283

1573

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.4

11.0

578

3726

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.6

11.0

308

1747

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

2.5

10.9

303

E61.1

ICD-10 Finland

Iron deficiency

1.7

10.9

213

1097

2462A

ICD-9 Finland

Other disorders of thyroid, Cyst of thyroid

+∞

10.9

F02.89*E03.9

ICD-10 Finland

Dementia in hypothyroidism, acquired

+∞

10.9

H03BB02

ATC

thiamazole; oral

+∞

10.9

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

1.4

10.9

512

3236

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.2

10.9

2491

19102

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.4

10.8

518

3282

R31

ICD-10 Finland

Unspecified haematuria

1.2

10.8

1634

12072

F43.00

ICD-10 Finland

Acute stress reaction mild

1.6

10.8

245

1317

A10AD04

ATC

insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

10.8

299

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

2.1

10.8

123

522

N02CC05

ATC

almotriptan; oral

1.5

10.8

332

1927

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.7

10.8

224

1176

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

10.8

1126

8000

C08CA05

ATC

nifedipine; systemic

1.3

10.7

809

5513

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

10.7

471

2941

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

9.2

10.7

168

Kela drug reimbursment

Axitinib

9.2

10.7

S01

ICPC

Pain/tenderness of skin

1.4

10.7

475

2970

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

10.7

472

2949

G04BD12

ATC

mirabegron; oral

1.3

10.7

1028

7231

ULC02

NOMESCO Finland

Hysteroscopy

2.0

10.7

142

641

R51

ICD-10 Finland

Headache

1.4

10.7

577

3737

N06AX17

ATC

milnacipran; oral

2.3

10.7

380

4451

FHL

Guitar cutting

1.4

10.7

597

3889

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

10.7

406

2466

ECB00

NOMESCO Finland

Suture of gingiva

1.4

10.7

467

2913

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.0

10.7

125

540

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.6

10.6

258

1413

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.6

10.6

238

1276

W29

ICPC

Pregnancy symptom/complaint other

1.4

10.6

434

2672

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

4.2

10.6

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.3

10.6

819

5601

Angiography of the heart and coronary arteries

1.3

10.6

976

6830

R06.2

ICD-10 Finland

Wheezing

1.4

10.5

504

3196

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

10.5

679

4523

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

3.0

10.5

176

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

10.5

3864

30643

SFA00

NOMESCO Finland

Small filling

1.2

10.5

1528

11249

342

Kela drug reimbursment

Dronedarone

2.3

10.5

360

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

3.2

10.5

154

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013826) Glucose [Moles/volume] in Serum or Plasma

32013

172294

1.48

307.65

4.9

4.6

mmol/l

6.7

3.43

29868

159267

(3000963) Hemoglobin [Mass/volume] in Blood

55327

342439

2.20

307.65

24.7

19.3

g/l

134.1

134.9

42.64

54708

337686

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8093

24253

2.37

307.65

2.6

2.1

nmol/l

366.4

380.4

6.71

7395

22381

(3044889) 12 lead EKG panel

36178

202124

1.45

307.65

4.0

3.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1732

194

60.10

307.65

7.1

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2260

849

18.06

307.65

5.9

1.2

u/ml

97.6

71.9

0.67

806

155

(3018010) Neutrophils/100 leukocytes in Blood

27015

143337

1.43

307.65

6.0

5.8

56.7

57.4

18.57

25229

134327

(3013115) Eosinophils [#/volume] in Blood

29615

154345

1.52

307.65

6.2

6.0

e9/l

0.2

8.28

26307

135776

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2510

5801

2.91

307.65

1.3

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

41643

220090

1.84

307.65

4.4

3.9

mm/h

12.0

11.7

3.85

38677

204121

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

26227

118340

1.82

307.65

2.5

2.2

nmol/l

77.0

842.5

0.50

23834

107019

(3015377) Calcium [Moles/volume] in Serum or Plasma

20754

94068

1.69

307.65

3.2

3.3

mmol/l

2.3

2.4

31.49

18256

82200

(3013650) Neutrophils [#/volume] in Blood by Automated count

32657

172012

1.55

307.65

9.3

8.8

e9/l

4.0

4.1

19.11

28843

150227

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

54251

273394

5.58

307.65

10.6

3.3

mu/l

2.1

0.53

51452

250622

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

53743

323014

2.18

307.65

11.7

9.6

u/l

25.8

25.9

0.40

52091

311748

(3018418) pH of Serum or Plasma

18430

81785

1.69

307.65

4.6

3.9

7.4

1.97

3858

15131

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

18420

91801

1.46

307.65

2.8

2.5

u/l

55.8

58.7

5.84

16966

84702

(3010813) Leukocytes [#/volume] in Blood

55330

342389

2.21

307.65

24.6

19.3

e9/l

6.7

6.8

2.76

54148

332486

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

23633

116242

1.55

307.65

2.1

1.9

pmol/l

97.7

95.6

8.38

12680

61620

(3001604) Monocytes [#/volume] in Blood

28568

148746

1.50

307.65

6.0

5.7

e9/l

0.6

11.00

25076

128914

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

47382

267993

1.85

307.65

6.4

5.3

mmol/mol

40.0

39.2

50.84

44009

248867

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1092

1769

4.09

307.65

2.5

1.9

nmol/l

18.0

19.7

5.48

1035

1676

(3020564) Creatinine [Moles/volume] in Serum or Plasma

53539

321489

2.14

307.65

18.1

15.1

umol/l

76.2

76.0

0.55

53522

321316

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

51679

305898

1.95

307.65

15.7

13.3

mg/l

20.4

23.8

97.91

42463

240219

(3001019) Free T4 and TSH panel - Serum or Plasma

5769

14643

2.75

307.65

2.5

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

49490

287511

1.85

307.65

5.0

4.2

mmol/l

5.9

23.14

45524

263812

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

16024

73355

1.59

307.65

2.4

2.2

mg/l

2.9

1.13

13756

62580

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

49316

292287

1.68

307.65

4.7

4.0

mmol/l

1.5

20.03

45647

271339

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

53387

222188

8.15

307.65

9.2

2.5

pmol/l

15.4

14.4

307.65

50665

200954

(40761511) CBC panel - Blood by Automated count

53062

319441

2.00

307.65

15.6

12.3

—

(3019069) Monocytes/100 leukocytes in Blood

26724

140996

1.44

307.65

6.5

6.2

8.4

8.5

1.72

24999

132206

(3019198) Lymphocytes [#/volume] in Blood

29395

153690

1.51

307.65

6.0

5.8

e9/l

2.0

1.9

0.99

26219

135639

(3001122) Ferritin [Mass/volume] in Serum or Plasma

28366

136170

1.71

307.65

3.4

2.8

ug/l

105.3

117.2

13.06

26351

126899

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17201

84726

1.46

307.65

2.2

2.1

u/l

178.0

209.3

4.26

16112

79514

(3007164) IgA [Mass/volume] in Serum or Plasma

12643

58368

1.53

307.65

1.5

1.4

g/l

2.3

2.4

5.26

7746

35828

(3026361) Erythrocytes [#/volume] in Blood

55323

342322

2.21

307.65

24.5

19.2

e12/l

4.5

9.29

54136

332429

(3035941) MCH [Entitic mass]

55318

342249

2.21

307.65

24.4

19.1

30.2

30.3

28.48

54696

337486

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

27140

125752

1.77

307.65

6.5

5.8

mmol/l

1.2

0.73

24697

113844

(3031040) Bacteria [#/volume] in Urine by Automated count

36069

202605

1.43

307.65

4.8

4.2

e6/l

1318.8

1358.4

0.05

529

2783

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

12483

9800

10.33

307.65

4.6

1.7

pmol/l

4.5

0.38

11289

8674

(3006315) Basophils [#/volume] in Blood

28700

149469

1.50

307.65

6.0

5.8

e9/l

0.0

0.00

25152

129518

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

50446

299572

1.77

307.65

5.3

4.5

mmol/l

2.8

0.02

46752

277567

(3006504) Eosinophils/100 leukocytes in Blood

26577

140275

1.44

307.65

6.2

5.9

2.9

2.8

11.24

24718

130848

(3007461) Platelets [#/volume] in Blood

55310

342009

2.22

307.65

24.6

19.3

e9/l

257.2

252.9

44.25

54243

333074

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

30012

138912

1.85

307.65

7.2

6.4

mmol/l

1.2

0.24

25019

117374

(3019550) Sodium [Moles/volume] in Serum or Plasma

52699

307203

2.32

307.65

17.8

14.9

mmol/l

139.6

1.24

51485

299075

(3023103) Potassium [Moles/volume] in Serum or Plasma

52782

308063

2.33

307.65

18.0

15.0

mmol/l

4.0

2.95

51479

299355

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

11151

15192

5.70

307.65

1.3

1.1

iu/ml

193.0

83.4

107.24

4954

4969

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

13254

58915

1.61

307.65

1.7

1.6

pmol/l

25332925.6

37167453.6

1.64

10978

49178

(3019309) Folate [Moles/volume] in Red Blood Cells

11498

51099

1.59

307.65

1.8

1.7

nmol/l

1183.9

1159.4

1.93

8871

38717

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

48394

281438

1.75

307.65

14.3

12.2

ml/min/173m2

82.5

83.6

19.60

40764

230279

(3022096) Basophils/100 leukocytes in Blood

25790

135899

1.43

307.65

6.2

6.0

0.7

3.31

24008

126797

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

49687

294528

1.71

307.65

4.8

4.1

mmol/l

4.7

0.33

46240

274563

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

28633

151132

1.47

307.65

6.0

umol/l

10.6

11.4

19.11

26961

142923

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

5490

3236

12.14

307.65

2.3

1.2

iu/l

21.7

7.0

0.83

2502

704

(3037467) Urinalysis macro (dipstick) panel - Urine

37406

211204

1.44

307.65

4.7

4.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

687

525

8.64

307.65

1.5

1.2

pmol/l

15.3

13.7

4.20

581

445

(3024561) Albumin [Mass/volume] in Serum or Plasma

24223

123929

1.48

307.65

4.7

g/l

35.7

35.6

2.94

22413

114871

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5825

18677

2.15

307.65

3.7

3.9

ng/l

78.1

94.5

30.30

5028

16194

(3002030) Lymphocytes/100 leukocytes in Blood

27467

145442

1.44

307.65

6.3

6.0

28.6

28.0

14.09

25577

135700

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

15089

66901

1.64

307.65

1.4

1.3

u/ml

1.4

1.7

1.52

4386

17908

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

42210

226212

1.80

307.65

7.9

7.2

u/l

77.2

77.5

0.55

39889

212798

(3024731) MCV [Entitic volume]

55320

342299

2.21

307.65

24.5

19.2

90.8

0.38

54698

337521

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

47839

281841

1.62

307.65

4.3

3.7

mmol/l

1.3

77.64

44008

260244

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

20682

106372

1.42

306.79

3.8

3.4

ng/l

65.6

65.3

0.01

13234

68670

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11141

51105

1.53

294.51

1.3

iu/ml

30.9

35.1

0.85

3367

15993

(3037522) Nuclear Ab [Titer] in Serum

9186

40369

1.58

293.73

1.4

1.3

titre

531.3

540.4

0.17

2091

7948

(3022948) Iron [Moles/volume] in Serum or Plasma

10084

45295

1.55

293.04

2.6

2.4

umol/l

13.4

13.7

0.28

9221

42025

(40760892) CBC W Ordered Manual Differential panel - Blood

13909

66894

1.47

291.96

4.5

4.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10561

48103

1.53

287.49

1.3

u/ml

10.3

11.8

1.29

4321

18677

(3021589) Normoblasts [#/volume] in Blood

24792

132634

1.39

286.03

10.4

9.1

e9/l

0.0

0.25

20679

108552

(42870588) Differential panel, method unspecified - Blood

19554

100659

1.41

281.85

5.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

13399

64830

1.46

268.69

1.6

1.5

nmol/l

20.7

20.2

2.68

11629

55867

(3035350) Ketones [Presence] in Urine by Test strip

27322

149566

1.37

266.29

4.0

3.4

estimate

0.0

2.33

5821

27595

(3021601) Nitrite [Presence] in Urine by Test strip

27356

149881

1.36

264.43

5.3

4.7

estimate

0.0

0.64

5929

28341

(3009508) Creatinine [Moles/volume] in Urine

17259

87686

1.41

263.85

3.5

3.2

mmol/l

7.4

7.9

2.42

14559

73844

(3009261) Glucose [Presence] in Urine by Test strip

27604

151510

1.36

263.41

4.0

3.5

estimate

0.0

0.75

5758

27581

(3020682) Albumin/Creatinine [Ratio] in Urine

16628

84093

1.41

260.13

4.3

4.0

mg/mmol

10.1

9.6

0.38

10382

53660

(3013512) EKG study

15837

79547

1.41

256.87

4.1

3.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9230

41723

1.53

256.61

2.6

2.4

g/l

2.4

2.3

10.44

8412

38600

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10756

50264

1.49

255.19

2.9

3.0

mmol/l

2.4

13.79

9328

43705

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15215

76036

1.42

253.19

3.3

2.9

ng/l

1346.1

1444.0

1.76

12854

64748

(3012516) Albumin [Mass/volume] in Urine

15847

79896

1.41

250.18

3.5

3.2

mg/l

455.6

420.0

0.38

9890

50956

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5491

22030

1.69

248.66

4.0

3.7

mmol/l

1.2

6.39

4777

19220

(3021387) Prolactin [Units/volume] in Serum or Plasma

3439

11986

1.93

246.97

2.0

1.5

mu/l

344.5

307.8

2.79

3069

10794

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9770

45104

1.50

244.62

3.4

mmol/l

0.8

4.79

9078

42051

(3023323) Follitropin [Units/volume] in Serum or Plasma

4280

16187

1.79

237.83

1.4

1.3

iu/l

25.4

27.2

2.67

3670

14014

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8061

35906

1.54

237.75

5.9

5.8

mmol/l

1.0

1.28

7447

33546

(3035637) Corticotropin [Mass/volume] in Plasma

1298

3026

2.84

232.31

1.7

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

35302

203292

1.34

231.47

3.4

2.9

u/l

45.9

45.7

0.15

32989

190646

(3009214) Lutropin [Units/volume] in Serum or Plasma

2730

8965

2.04

231.30

1.4

1.3

u/l

10.6

10.1

0.89

2211

7364

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8496

38678

1.51

225.36

2.7

2.5

22.6

22.8

0.88

7207

33010

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13126

65286

1.41

218.19

2.0

1.7

mg/l

1.1

1.2

3.97

9893

49673

(40768797) Stomach Pathology biopsy report

8469

38786

1.50

217.53

1.2

—

(40768804) Tissue Pathology biopsy report

22551

122359

1.33

215.85

2.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

21474

115804

1.34

213.58

4.2

3.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1664

4607

2.40

212.43

2.7

3.3

—

(3026008) Bacteria identified in Urine by Culture

17032

88892

1.36

209.27

3.1

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

15598

80354

1.37

207.92

4.4

3.8

estimate

0.0

0.14

5759

27181

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18438

97916

1.34

199.64

3.3

3.2

u/l

31.9

33.2

1.50

17422

92862

(3015736) pH of Urine

21401

116358

1.32

195.73

3.7

3.2

5.7

0.08

(3019225) pH of Specimen

6151

26885

1.55

194.15

4.7

4.0

—

(3032080) INR in Blood by Coagulation assay

21127

114851

1.32

192.41

9.1

8.5

inr

1.2

2.67

6599

33285

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

757

1458

3.42

184.67

13.5

11.6

mmol/l

0.7

0.6

6.92

693

1340

(40758558) Short blood count panel - Blood

14352

74564

1.34

174.72

6.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

14254

74279

1.34

168.90

1.7

1.6

mmol/l

1.4

1.3

16.24

11861

63042

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

489

725

4.44

168.53

2.4

2.2

ug/l

1.1

0.09

455

693

(3044640) Blood type and Crossmatch panel - Blood

17759

95687

1.31

165.38

2.4

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

42677

257412

1.32

164.03

19.1

15.9

13.7

13.6

6.46

41861

252063

(3026493) Urate [Moles/volume] in Serum or Plasma

14511

76128

1.33

163.05

2.6

umol/l

3839.6

4274.1

0.65

12526

66404

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25621

145050

1.28

161.24

4.1

4.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2979

11449

1.74

154.45

1.3

1.2

u/ml

0.8

0.9

0.07

262

974

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1546

4929

2.08

140.70

1.4

1.3

u/l

23.6

25.6

1.42

1257

4087

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11115

90603

0.75

139.03

5.1

5.0

ug/l

2.9

3.5

1.30

9803

81209

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1279

3830

2.21

136.17

1.8

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

15264

82238

1.29

135.79

3.6

3.1

—

(40761536) Microorganisms panel - Urine sediment

5594

25785

1.46

133.68

4.0

3.7

—

(3018095) Leukocytes [#/volume] in Urine

19125

106232

1.26

131.90

3.9

3.6

e6/l

90.4

96.5

0.44

13723

73858

(3048689) Calprotectin [Mass/mass] in Stool

7722

37837

1.38

131.10

2.1

2.4

ug/g

126.1

129.6

0.35

5945

29680

(3026782) Osmolality of Urine

11089

57469

1.32

130.58

2.9

2.7

mosm/kgh2o

529.9

551.2

18.73

9533

48764

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8610

72204

0.74

129.68

4.5

4.3

22.5

22.0

2.08

4159

35419

(36660697) Celiac disease serology panel - Serum

5226

24184

1.45

121.65

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3400

14382

1.58

120.92

1.1

titre

89.6

219.4

6.02

367

(3000850) Epithelial cells [#/volume] in Urine

11762

62015

1.30

120.76

2.7

2.6

e6/l

6.2

5.8

1.82

10311

54000

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1507

5087

1.96

117.22

1.6

1.4

nmol/l

0.4

0.38

1191

4044

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

10586

55331

1.31

115.12

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

276

358

5.06

110.55

1.8

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

5148

24179

1.43

110.04

4.1

1.0

0.9

0.96

1418

6619

(3002179) Metamyelocytes/100 leukocytes in Blood

4732

21934

1.45

108.52

3.9

0.8

0.6

1.75

1024

4763

(3021440) Promyelocytes/100 leukocytes in Blood

4921

22985

1.44

108.32

4.2

4.1

0.1

0.55

1308

6128

(3002582) Erythrocytes [#/volume] in Urine

16171

89811

1.24

105.43

3.4

3.2

e6/l

96.2

91.0

0.13

12605

68407

(3005719) IgG [Mass/volume] in Serum or Plasma

4666

21739

1.44

103.89

2.7

g/l

10.5

10.6

0.33

4239

19949

(3025159) Blasts/100 leukocytes in Blood

4655

21693

1.44

103.49

4.2

4.1

0.3

0.2

0.32

1123

5172

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

11421

61062

1.28

102.52

1.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5860

28522

1.38

101.46

3.5

3.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13303

72535

1.26

101.13

2.3

—

(3030467) Casts [#/volume] in Urine by Automated count

14850

81993

1.25

101.10

3.2

3.1

e6/l

0.4

3.00

11397

61231

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6070

51949

0.74

101.07

3.1

3.0

ug/l

0.7

0.8

3.61

4154

34791

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6918

34598

1.35

100.85

7.6

6.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

7001

35118

1.34

99.98

1.8

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2050

8003

1.70

99.67

1.3

u/ml

31.6

35.8

0.31

141

466

(36304419) Bacteria [Presence] in Urine

14494

80164

1.24

96.15

3.2

3.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6302

31282

1.35

96.10

2.6

2.5

1.8

1.7

1.56

5513

27648

(3009542) Hematocrit [Volume Fraction] of Blood

45819

284387

1.25

94.03

17.0

14.1

39.4

39.7

8.30

32506

211756

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

34521

208239

1.21

93.83

3.4

3.2

—

(3023368) Bacteria identified in Blood by Culture

14057

77658

1.24

93.74

4.3

4.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8842

46273

1.29

92.64

1.9

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6789

34258

1.33

92.54

4.7

4.2

32.1

32.5

1.93

4912

23719

(3005322) IgE [Units/volume] in Serum or Plasma

4131

19231

1.43

91.86

1.3

u/ml

185.6

245.4

1.57

3809

17827

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2209

8999

1.63

91.18

2.0

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1137

3849

1.95

87.64

6.2

4.7

umol/l

382.1

360.3

5.19

997

3292

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1850

7291

1.68

86.72

1.3

u/ml

5.6

7.3

0.51

220

742

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1872

7409

1.67

86.36

1.3

u/ml

10.9

7.9

0.86

327

1132

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3771

17458

1.44

86.19

3.8

3.6

kpa

5.1

0.79

3486

16107

(3009343) pH of Capillary blood

3730

17241

1.44

85.96

3.8

3.6

7.4

0.13

534

2200

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3622

16654

1.45

85.83

3.7

3.5

mmol/l

1.7

1.6

0.17

2692

12128

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2134

8795

1.61

83.95

1.8

1.7

g/l

0.2

0.23

2011

8341

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2185

9072

1.60

83.37

1.8

1.7

g/l

1.2

4.14

2063

8635

(3019150) Specific gravity of Urine by Refractometry

11976

65714

1.24

83.14

4.4

3.8

kg/l

1.0

0.54

1751

10194

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2738

11997

1.52

82.35

2.0

1.9

u/l

39.4

39.1

0.32

2469

10654

(3020630) Protein [Mass/volume] in Serum or Plasma

4587

22203

1.38

81.07

2.4

2.6

g/l

66.4

66.5

0.47

4166

20181

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1555

5978

1.72

79.77

1.3

1.2

u/ml

43.7

0.00

183

566

(3011397) Hemoglobin [Presence] in Urine by Test strip

12692

70434

1.23

78.44

4.0

3.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3610

16878

1.42

77.92

1.7

1.9

g/l

1.2

1.3

4.22

3272

15429

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

910

2974

2.02

77.44

1.3

nmol/l

32.5

28.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6340

32469

1.31

76.71

4.4

4.1

u/l

241.3

241.4

0.02

5975

30665

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6984

36362

1.29

74.48

1.8

—

(3022145) Colonoscopy Study observation

6311

32449

1.30

73.96

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5256

26369

1.33

73.33

2.3

g/l

0.2

2.07

4879

24485

(3017732) Neutrophils [#/volume] in Blood

4263

20727

1.37

72.95

2.8

2.7

e9/l

4.1

0.39

3349

16107

(3023520) Reticulocytes [#/volume] in Blood

4662

23007

1.35

72.56

2.6

e9/l

71.3

68.9

3.99

3568

17286

(3033658) Prothrombin time (PT) actual/Normal

13349

74959

1.21

72.27

4.0

3.9

92.1

90.4

10.91

12902

73086

(3000494) Fungus identified in Specimen by Culture

6529

33828

1.29

72.09

1.5

1.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

131

125

6.86

70.04

4.7

1.2

pmol/l

120.4

8.3

1.76

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4161

20320

1.36

69.12

2.4

2.3

au/ml

21.5

23.8

0.63

211

1244

(3004588) Protein electrophoresis panel - Serum or Plasma

3745

18014

1.38

68.27

2.1

2.4

—

(3025941) Bacteria identified in Stool by Culture

3652

17567

1.38

66.51

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2683

12222

1.46

66.31

1.1

u/ml

7.4

9.1

0.12

177

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3348

15885

1.40

66.14

2.3

2.2

u/l

5548.0

6202.9

0.60

1334

6415

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3821

18554

1.37

65.64

1.3

au/ml

44.1

49.8

0.73

144

757

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

583

1712

2.24

65.14

1.4

1.2

umol/l

4.9

5.4

1.22

539

1585

(3010421) pH of Blood

1747

7304

1.58

64.59

4.1

3.8

7.4

0.77

1485

6238

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1490

6001

1.64

64.17

1.3

1.2

u/ml

6.0

5.8

0.03

124

442

(3013139) Helicobacter pylori Ag [Presence] in Stool

4042

19872

1.35

64.12

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

420

1076

2.56

63.09

1.5

1.4

mu/l

668.3

664.6

0.01

392

1030

(3011985) Renin [Units/volume] in Plasma

1007

3651

1.82

63.03

2.0

1.4

mu/l

70.2

58.0

1.02

899

3267

(40761535) Cells panel - Urine sediment

4667

23499

1.32

62.99

3.8

3.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

425

1106

2.52

61.87

1.5

1.4

72.3

73.1

0.48

397

1060

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5063

25850

1.31

61.78

4.1

3.9

kpa

5.9

5.8

1.79

4890

25095

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6370

33516

1.27

61.52

2.5

2.7

umol/l

7.6

8.5

2.59

5403

28919

(3002032) Base excess in Venous blood by calculation

5044

25784

1.30

60.96

4.2

4.0

mmol/l

1.9

1.8

0.37

4129

21004

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1464

5947

1.62

60.94

1.3

1.2

u/ml

17.6

13.7

0.14

(1761868) Lipid panel - Serum or Plasma

18499

108175

1.17

60.88

3.0

2.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

4862

24759

1.31

60.40

8.4

7.2

mmol/l

9.7

9.8

0.45

4606

23517

(3022313) Gas panel - Capillary blood

2658

12342

1.43

59.18

3.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

7059

37761

1.25

59.06

1.7

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1766

7567

1.54

58.62

2.1

2.0

mg/l

10.6

10.9

0.75

1648

7050

(1616796) Gas panel - Central venous blood

1529

6340

1.59

58.51

3.8

3.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4164

20871

1.33

57.79

1.6

—

(3012544) pH of Venous blood

5182

26797

1.29

57.18

4.2

3.9

7.4

0.75

129

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1840

8011

1.52

56.75

1.4

ug/g

281.9

272.7

1.03

1039

4586

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3339

16257

1.36

56.13

1.1

—

(3002256) Pathology report gross observation

7257

39147

1.24

56.07

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

1531

6415

1.57

56.05

4.2

3.9

kpa

8.7

8.6

0.53

1495

6267

(3007566) Smooth muscle Ab [Titer] in Serum

1806

7853

1.52

56.03

1.2

titre

124.8

121.1

0.08

164

725

(3022217) INR in Platelet poor plasma by Coagulation assay

6812

36527

1.25

55.51

24.3

23.8

inr

1.3

1.4

1.60

959

5259

(3012501) Base excess in Blood by calculation

1519

6381

1.57

55.00

4.2

3.8

mmol/l

2.5

0.06

1012

4246

(3013290) Carbon dioxide [Partial pressure] in Blood

1519

6383

1.57

54.93

4.2

3.8

kpa

5.0

0.29

1483

6236

(3030313) Adrenal Ab [Titer] in Serum

158

234

4.42

54.88

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

429

1191

2.36

54.56

1.7

1.5

mmol/24h

6.1

5.3

0.56

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1941

8637

1.48

53.90

1.1

u/ml

4.9

5.6

0.28

245

1143

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3248

15849

1.36

53.77

3.1

3.2

u/ml

42.5

48.2

0.53

3127

15301

(3034770) Mitochondria Ab [Titer] in Serum

1772

7746

1.51

53.62

1.2

titre

1044.1

960.7

0.18

218

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2332

10768

1.43

53.45

4.0

3.9

mmol/l

24.8

24.7

0.62

2156

9946

(4010399)

4042

20440

1.31

52.49

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

925

3457

1.76

52.41

1.4

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2110

9606

1.45

52.15

1.7

1.6

titre

309.0

273.2

0.25

110

367

(43055514) Macroprolactin [Presence] in Serum or Plasma

325

806

2.64

52.14

1.5

1.3

—

(3008295) Osmolality of Serum or Plasma

722

2512

1.89

51.48

1.7

1.4

mosm/kgh2o

281.7

279.6

1.55

578

1929

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2589

12291

1.39

50.68

1.5

u/ml

12.5

15.3

0.55

327

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

632

2115

1.96

50.50

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8017

44275

1.21

48.70

2.3

2.1

29.9

29.8

0.39

7777

42924

(3042936) Bacteria identified in Isolate by Culture

7555

41520

1.22

48.18

2.0

—

(4035726)

4737

24756

1.27

47.60

1.4

—

(3003181) Sodium [Moles/volume] in Urine

1087

4386

1.63

46.52

1.5

1.4

mmol/l

66.2

62.9

1.64

876

3473

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2995

14769

1.34

46.13

2.5

2.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9743

55030

1.19

46.11

3.9

3.6

ng/l

339.7

515.0

3.17

7022

40833

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4463

23277

1.27

45.50

2.4

2.3

ug/l

7.0

7.3

0.34

3836

20189

(3016244) Insulin [Units/volume] in Serum or Plasma

562

1877

1.97

45.23

2.8

3.3

mu/l

29.4

26.7

0.67

537

1760

(3008898) HLA-B27 [Presence]

2271

10751

1.40

45.13

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1066

4322

1.62

44.77

1.4

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

4103

21219

1.28

44.74

3.7

3.3

kpa

4.6

0.22

3947

20501

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5852

31592

1.23

44.08

1.8

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

963

3828

1.65

43.71

1.3

nmol/l

2.3

1.2

0.42

928

3679

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

959

3813

1.65

43.49

1.3

nmol/l

0.3

0.2

0.36

256

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

885

3447

1.69

43.38

1.3

—

(40768443) Skin Pathology biopsy report

2588

12618

1.36

42.89

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5864

31764

1.23

42.69

1.8

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1378

5996

1.51

42.62

3.4

3.6

57.0

57.8

1.56

1378

5991

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2341

11309

1.37

41.12

1.5

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6439

35344

1.21

41.02

7.2

7.0

mmol/l

104.3

104.5

2.99

6302

34565

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

406

1253

2.13

40.42

1.7

1.6

nmol/l

3.4

9.5

0.73

340

1048

(3027273) Bicarbonate [Moles/volume] in Venous blood

2666

13178

1.34

40.32

3.5

3.4

mmol/l

25.2

0.31

2573

12803

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1042

4315

1.59

40.16

1.3

—

(1002224) Polysomnography panel

2448

11958

1.35

40.04

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3258

16585

1.30

39.98

3.7

3.4

g/l

129.1

128.9

0.22

3166

16222

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1253

5418

1.52

39.92

1.3

ug/l

3.1

3.7

2.44

1132

4913

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3351

17155

1.29

39.38

7.3

7.0

mmol/l

24.7

0.10

3314

17008

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3348

17159

1.29

39.00

1.5

—

(3000991) Gas panel - Venous blood

4450

23627

1.25

38.74

8.5

8.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

900

3635

1.63

38.44

1.3

1.2

u/ml

49.2

52.2

0.14

225

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9730

55691

1.17

38.34

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

1350

5981

1.49

38.31

2.7

2.5

16.6

16.4

1.17

712

3077

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2458

12109

1.34

38.01

2.1

2.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8857

50433

1.17

37.07

2.8

2.7

e6/l

1.1

1.2

0.45

5121

28487

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

856

3452

1.63

36.80

1.4

1.3

pmol/l

383.7

286.0

1.70

656

2677

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6717

37380

1.20

36.69

1.8

1.7

1.4

0.12

5878

33020

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2298

11269

1.35

36.62

1.6

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

463

1569

1.94

35.87

1.1

nmol/l

4.9

5.5

0.11

298

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5053

27422

1.22

35.76

2.5

u/l

36.1

45.7

1.95

4256

23526

(3014111) Lactate [Moles/volume] in Serum or Plasma

4609

24787

1.23

35.57

7.1

6.9

mmol/l

1.3

1.4

0.76

4430

23868

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4474

24014

1.24

35.15

1.5

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2548

12765

1.32

35.06

3.4

2.9

1.2

1.3

1.51

2534

12701

(3003327) Ova and parasites identified in Stool by Light microscopy

2130

10423

1.35

34.41

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1441

6608

1.44

34.26

2.5

2.4

ug/min

119.2

106.7

0.42

878

3920

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2238

11047

1.34

34.12

1.9

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2492

12494

1.32

34.10

3.4

2.9

0.7

0.06

2403

11995

(3020891) Body temperature

2199

10840

1.34

33.83

5.3

4.9

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1227

5487

1.47

33.28

1.3

1.2

titre

109.3

132.2

0.23

105

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4304

23137

1.23

33.26

2.8

2.6

ml/min/173m2

65.0

67.7

3.63

1868

9013

(3037121) Protein [Mass/volume] in Urine

2006

9790

1.35

32.98

3.1

g/l

0.4

0.3

0.59

855

4363

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1040

4506

1.52

32.89

1.1

iu/ml

1154.7

2558.5

0.25

277

983

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1517

7086

1.41

32.58

3.5

2.9

mmol/l

24.8

24.5

1.44

1351

6223

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2423

12178

1.31

32.56

4.3

3.9

49.2

47.9

1.75

2393

12045

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

9.15

32.52

1.5

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2267

11292

1.32

32.47

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5768

31989

1.20

32.44

7.3

7.2

kpa

5.1

0.03

5488

30508

(3027801) Oxygen [Partial pressure] in Arterial blood

5761

31975

1.20

32.11

7.3

7.2

kpa

12.3

12.6

3.50

5479

30486

(3003396) Base excess in Arterial blood by calculation

5761

31996

1.20

31.86

7.3

7.2

mmol/l

1.1

1.0

0.59

4490

25038

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1370

6316

1.43

31.67

1.4

—

(3016502) Oxygen saturation in Arterial blood

5180

28515

1.21

31.51

7.6

95.6

95.7

0.39

4979

27448

(3012565) Volume of 24 hour Urine

394

1332

1.94

30.83

2.0

2.2

2075.0

1956.9

1.31

357

1188

(3038026) Centromere Ab [Units/volume] in Serum

586

2248

1.71

30.53

1.3

1.2

u/ml

51.4

46.0

0.14

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1654

7932

1.37

30.40

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

574

2194

1.72

30.30

1.2

u/ml

57.5

73.3

0.55

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1414

6612

1.41

30.20

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

574

2199

1.71

30.06

1.2

u/ml

51.5

40.3

0.52

151

(3028626) Oxygen [Partial pressure] in Capillary blood

1399

6547

1.41

29.75

3.4

3.2

kpa

8.4

8.3

0.95

1297

6090

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1660

8010

1.36

29.36

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3134

16488

1.26

29.34

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1781

8693

1.35

29.27

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

1138

5148

1.45

29.14

2.9

2.8

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

550

2102

1.72

29.07

1.2

u/ml

13.6

7.4

0.57

137

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1568

7558

1.37

27.94

3.6

mg/l

1.6

1.5

1.47

1432

6969

(46235355) HIV 1 and 2 tests - Meaningful Use set

11285

66600

1.13

27.57

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2502

12910

1.28

27.51

1.8

1.7

g/l

1.5

0.27

2110

11043

(3028271) Lactate [Moles/volume] in Capillary blood

1000

4462

1.47

27.50

2.0

1.8

mmol/l

1.7

1.02

977

4352

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8177

47239

1.15

27.44

3.1

2.8

e6/l

3.6

3.0

4.13

4484

25458

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1624

7901

1.35

27.27

1.6

1.4

iu/ml

18.8

12.8

0.75

175

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2929

15427

1.25

27.12

2.9

2.7

e6/l

0.3

0.02

2857

14970

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1530

7382

1.36

27.10

1.3

mg/l

506.9

531.2

0.56

1460

7034

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

999

4486

1.46

26.62

1.1

u/ml

3.2

3.0

0.13

460

2183

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1588

7730

1.35

26.58

2.0

1.6

nmol/l

43.4

0.02

1550

7517

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

984

4428

1.46

25.95

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1384

6622

1.37

25.84

2.3

2.2

g/l

130.7

129.8

0.63

994

4871

(3019060) Gas panel - Arterial blood

3406

18339

1.23

25.75

4.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1198

5598

1.41

25.75

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

832

3626

1.51

25.71

1.4

—

(3000492) Spirometry study

5095

28508

1.18

25.61

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

830

3621

1.50

25.53

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1031

4698

1.44

25.47

1.6

1.5

g/l

0.7

1.50

738

3590

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1191

5571

1.41

25.45

2.3

2.0

nmol/l

0.9

0.8

2.12

958

4701

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2259

11621

1.28

25.45

1.8

1.6

mg/l

3.9

3.5

1.42

1729

7910

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1341

6400

1.38

25.44

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

830

3624

1.50

25.43

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

837

3667

1.50

25.24

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

701

2955

1.56

25.23

1.2

u/l

61.4

62.7

0.16

472

1988

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

835

3666

1.50

24.93

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

852

3760

1.49

24.80

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1120

5211

1.41

24.69

2.2

1.8

pmol/l

178.1

185.8

1.34

1045

4923

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4717

26313

1.19

24.52

8.1

8.0

g/l

121.4

121.3

0.05

4549

25380

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1346

6494

1.36

23.89

1.2

1.3

mmol/l

3.8

3.7

0.61

1262

6097

(3018405) Lactate [Moles/volume] in Arterial blood

1899

9632

1.30

23.87

4.3

4.2

mmol/l

1.3

1.4

1.76

1870

9454

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3233

17451

1.22

23.83

7.2

7.1

mmol/l

24.6

24.5

0.49

3015

16277

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1909

9693

1.30

23.80

2.3

ug/l

395.2

540.9

2.09

1749

9050

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

381

1389

1.80

23.79

1.1

u/l

89.1

84.4

0.30

295

1123

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1022

4713

1.42

23.69

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

428

1617

1.73

23.69

1.4

1.5

u/l

6.2

5.8

0.36

349

1362

(3048929) Epstein Barr virus Ab [Presence] in Serum

1990

10176

1.29

23.51

1.3

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

825

3659

1.48

23.47

1.9

1.8

90.0

89.8

0.30

813

3599

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

500

1977

1.66

23.43

1.4

1.3

umol/l

11.2

12.4

3.53

479

1876

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2566

13541

1.25

23.35

4.7

4.3

mmol/l

24.1

0.49

2306

12181

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

379

1389

1.79

23.27

1.2

1.1

u/l

25.2

24.9

0.02

284

1081

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1751

8821

1.31

23.16

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1343

6510

1.36

23.15

1.4

e6/l

33.1

28.9

0.15

1050

5024

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1451

7117

1.34

23.15

1.5

1.4

pmol/l

122.4

121.2

0.03

1415

6932

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

12.64

23.12

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1766

8909

1.30

23.12

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1343

6516

1.35

23.01

1.4

1.5

e6/l

1382.2

2303.3

0.56

1112

5279

(42529406) Shigella sp [Presence] in Stool by Culture

1767

8926

1.30

22.91

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

1750

8829

1.30

22.90

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1661

8339

1.31

22.54

3.0

3.4

mg/l

45.2

44.6

0.03

1346

6743

(3039443) Prostate specific Ag panel - Serum or Plasma

447

4742

0.61

22.51

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

464

1822

1.67

22.36

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

377

1399

1.77

22.23

1.4

1.5

umol/l

25.9

24.6

0.32

357

1335

(3027135) IgG subclass 1 [Mass/volume] in Serum

690

2986

1.52

22.13

1.5

1.3

g/l

6.7

6.8

0.29

452

2120

(3024139) IgG subclass 3 [Mass/volume] in Serum

689

2982

1.52

22.08

1.5

1.3

g/l

0.4

1.51

455

2127

(3034860) Kappa light chains.free [Mass/volume] in Serum

1660

8357

1.31

22.08

3.0

3.4

mg/l

86.1

57.8

0.39

1341

6753

(3028192) IgG subclass 2 [Mass/volume] in Serum

689

2983

1.52

22.05

1.4

1.3

g/l

3.0

0.03

454

2116

(3045414) Leukocytes [Presence] in Urine

2538

13465

1.24

22.01

1.9

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

327

1166

1.84

21.98

1.5

1.9

umol/l

2.0

1.07

309

1093

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4126

22975

1.19

21.81

3.3

2.8

ng/l

202.9

207.5

0.23

3751

20888

(4062490)

689

2991

1.51

21.78

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

567

2365

1.57

21.46

1.2

nmol/l

367.7

0.00

477

2012

(3014007) Fractional oxyhemoglobin in Arterial blood

3203

17474

1.21

21.18

9.3

9.1

93.9

0.09

3191

17409

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1607

8103

1.30

21.14

3.0

3.3

ratio

6.3

3.8

0.31

151

619

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

775

3471

1.47

21.05

2.2

2.0

mg/l

27.6

26.0

0.29

224

930

(40768800) Prostate Pathology biopsy report

578

5700

0.66

20.87

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1271

6212

1.34

20.80

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1992

10346

1.27

20.79

2.0

2.3

—

(3028707) Methadone [Presence] in Urine by Screen method

1169

5641

1.36

20.79

2.7

2.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1994

10358

1.27

20.78

2.0

2.3

g/l

7.4

0.22

1491

7689

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1988

10330

1.27

20.67

2.0

2.3

g/l

3.8

0.76

1423

7331

(3004809) Band form neutrophils/100 leukocytes in Blood

966

4526

1.40

20.54

3.3

1.5

1.4

0.24

770

3448

(3045424) Erythrocytes [Presence] in Urine

1047

4975

1.38

20.49

1.6

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1882

9736

1.27

20.30

2.1

2.3

g/l

3.0

3.1

2.09

1457

7523

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3704

20569

1.19

20.18

2.7

2.1

nmol/l

11.1

11.7

4.58

3244

18091

(4146454)

653

2850

1.50

20.17

3.0

2.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

440

1754

1.64

20.08

17.1

18.2

nmol/l

1460.3

3273.6

0.98

419

1674

(40768793) Breast Pathology biopsy report

1324

6555

1.33

19.88

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

420

1663

1.65

19.68

12.3

13.1

nmol/l

791.2

1441.4

0.56

406

1603

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5707

32868

1.15

19.52

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1009

4805

1.38

19.51

3.3

3.1

nmol/l

0.8

0.34

779

3664

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

428

1710

1.64

19.38

1.5

1.6

u/l

7.0

6.2

0.33

194

842

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3172

17446

1.20

19.23

9.3

9.1

0.7

0.26

3156

17333

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

144

396

2.38

19.11

1.1

pmol/l

3.1

7.9

0.51

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

276

977

1.85

19.06

2.9

umol/l

28.3

28.8

0.30

195

756

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1857

9666

1.26

19.05

2.0

2.3

g/l

10.1

10.3

0.72

1545

8039

(3023183) Ammonium ion [Moles/volume] in Plasma

1187

5826

1.34

18.93

2.8

2.7

umol/l

33.9

33.8

0.02

993

4909

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

512

2150

1.56

18.90

1.1

mg/l

298.2

429.4

0.47

449

1937

(3043409) Potassium [Moles/volume] in Arterial blood

1622

8313

1.28

18.88

4.6

4.4

mmol/l

3.9

0.40

1525

7797

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

809

3737

1.42

18.70

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1238

6136

1.33

18.48

1.3

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1698

8782

1.27

18.38

2.1

2.5

g/l

0.8

0.9

0.70

1455

7507

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3167

17491

1.19

18.33

9.2

9.0

1.4

0.02

3147

17368

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1637

8444

1.27

18.11

1.8

1.7

—

(3016038) Potassium [Moles/volume] in Urine

415

1675

1.62

18.10

1.4

1.2

mmol/l

34.1

35.0

0.35

348

1442

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

690

3122

1.45

17.87

3.3

3.2

nmol/l

4.5

8.3

1.31

654

3034

(40760888) Immunoglobulin light chains.free panel - Serum

1257

6289

1.31

17.58

3.1

3.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1236

6176

1.31

17.45

1.3

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2058

10958

1.24

17.30

2.0

ug/l

1.7

2.2

2.04

1806

9629

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

473

1992

1.56

17.29

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

469

1979

1.55

17.01

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

767

3575

1.41

16.91

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

524

2270

1.51

16.87

1.2

mmol/l

2.0

2.1

0.62

477

2114

(3003338) MCHC [Mass/volume]

41655

265591

1.09

16.84

20.9

16.7

g/l

331.7

332.5

53.35

41365

263407

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

421

1740

1.59

16.71

3.0

2.8

ug/l

21.2

26.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1765

9287

1.25

16.54

1.7

1.6

iu/ml

17.5

4.4

0.56

364

1984

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

531

2317

1.50

16.53

1.2

1.1

u/ml

58.4

56.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

537

2350

1.50

16.49

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

537

2350

1.50

16.49

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

537

2350

1.50

16.49

1.7

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

956

4641

1.35

16.46

1.3

1.2

u/ml

4.3

3.8

0.67

442

2047

(3008757) Leukocyte morphology finding [Identifier] in Blood

661

3016

1.44

16.42

3.6

—

(3003694) ABO and Rh group [Type] in Blood

14956

91633

1.09

16.31

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

492

2119

1.52

16.30

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

867

4161

1.37

16.08

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1059

5242

1.33

16.02

2.0

2.1

umol/l

6.3

0.01

750

3826

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1498

7769

1.27

15.90

2.0

2.3

g/l

0.0

0.53

1367

7073

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

552

2450

1.48

15.84

1.3

nmol/l

1.5

1.4

0.54

484

2232

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

990

4865

1.34

15.75

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1540

8027

1.26

15.68

1.9

2.2

g/l

37.9

37.7

0.63

1318

6862

(3023511) Choriogonadotropin [Units/volume] in Urine

1572

8218

1.26

15.61

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

595

2689

1.45

15.58

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

392

1621

1.58

15.57

1.4

1.5

ug/l

8.6

7.7

0.31

352

1472

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

377

1546

1.60

15.51

2.7

2.4

u/ml

1169.6

1054.6

0.23

370

1528

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1170

5904

1.30

15.43

5.3

5.7

iu/ml

959.3

1893.5

0.56

156

880

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

979

4826

1.33

15.26

1.3

1.2

u/ml

3.5

3.7

0.13

355

1641

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

163

521

2.05

15.22

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1154

5826

1.30

15.17

1.3

u/ml

283.1

263.1

1.31

718

3811

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

963

4763

1.33

14.69

1.2

1.1

au/ml

13.8

10.6

0.43

303

(44813793)

498

2200

1.48

14.68

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

689

3235

1.40

14.64

1.7

1.6

iu/ml

30.0

34.5

0.42

158

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

727

3447

1.38

14.58

2.1

2.2

32.5

32.7

0.38

720

3421

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

170

562

1.98

14.51

1.4

1.6

ug/l

0.4

1.00

396

(21494755) Public health laboratory ask at order entry panel

4419

32568

0.88

14.36

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

488

2157

1.48

14.36

1.4

nmol/l

28.7

32.4

2.02

438

1998

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

357

1479

1.58

14.13

1.2

1.1

u/ml

13.3

13.8

0.02

140

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

446

1942

1.50

14.12

1.4

1.6

u/ml

19.8

25.9

1.98

394

(3047007) Chlamydophila sp Ab [Presence] in Serum

902

4449

1.33

14.05

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1378

7194

1.26

13.90

2.0

2.3

g/l

0.0

0.00

1252

6522

(4034850)

1767

9480

1.22

13.89

11.4

9.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

519

2340

1.45

13.83

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6676

39621

1.11

13.82

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

784

3800

1.35

13.74

1.4

—

(4024509)

570

2620

1.43

13.70

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

929

4631

1.32

13.46

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

5.33

13.44

3.4

1.3

mu/l

2.2

2.8

0.27

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

624

2927

1.40

13.39

1.7

—

(3044927) Protein electrophoresis panel - Urine

560

2578

1.42

13.37

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

896

4450

1.32

13.33

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

972

4887

1.30

13.24

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1730

9308

1.22

13.24

3.7

3.1

u/ml

0.3

0.12

979

5296

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1354

7096

1.25

13.23

2.0

2.3

g/l

0.0

0.00

1246

6504

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

259

1008

1.68

13.16

1.2

112.9

110.4

0.80

231

898

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

275

1088

1.65

13.14

1.2

g/l

0.3

0.67

224

860

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

564

2609

1.42

13.11

3.8

u/ml

44.6

48.3

0.21

553

2588

(3036603) Volume of Urine

428

1879

1.49

13.07

1.6

1996.2

1946.6

0.20

107

425

(4306422)

924

4626

1.31

13.00

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

650

3088

1.38

12.95

1.5

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

894

4466

1.31

12.79

2.7

2.8

u/ml

1999.8

7059.8

0.88

248

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

894

4470

1.31

12.71

1.1

119.3

117.8

0.67

795

4042

(3022689) Creatine [Moles/volume] in Urine

204

750

1.78

12.68

1.6

1.4

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

156

526

1.94

12.67

1.3

1.4

nmol/l

5.7

6.6

0.51

146

503

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1225

6380

1.26

12.65

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

512

2344

1.43

12.63

1.9

2.0

g/24h

0.6

1.2

2.23

125

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

697

3365

1.36

12.58

1.1

iu/ml

2.3

2.0

—

(3036489) Thrombin time

2085

11478

1.19

12.57

2.3

2.0

21.4

21.5

0.09

1785

9926

(4268621)

657

3143

1.37

12.56

2.3

—

(3022621) pH of Urine by Test strip

3460

19844

1.15

12.45

3.2

2.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

389

1694

1.50

12.39

1.1

u/l

1.1

0.62

179

735

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

785

3868

1.33

12.38

1.1

g/l

1.5

0.97

709

3500

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

476

2159

1.44

12.36

1.3

u/ml

0.8

1.2

0.62

197

966

(3037756) Immunofixation for Serum or Plasma

1085

5586

1.27

12.35

1.6

1.7

—

(4094501)

1396

7403

1.24

12.30

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

510

2349

1.42

12.19

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

509

2346

1.42

12.13

1.2

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

130

418

2.03

12.07

1.3

mmol/24h

92.1

71.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

508

2345

1.42

12.01

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

845

4229

1.31

11.96

1.3

u/l

31.5

37.0

0.52

749

3660

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4906

28851

1.12

11.90

3.5

4.0

ug/l

19.0

25.5

0.84

3838

23096

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1962

10799

1.19

11.87

1.9

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1405

7488

1.23

11.84

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

652

3149

1.36

11.77

1.1

au/ml

73.8

64.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

427

1920

1.46

11.64

1.1

iu/ml

8.5

8.6

0.01

501

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

205

2.49

11.59

1.5

1.3

pmol/l

19.0

12.2

0.44

176

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

513

2389

1.41

11.56

1.2

titre

159.7

172.6

0.15

404

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

237

936

1.66

11.48

2.6

2.4

nmol/l

154.6

153.1

0.08

218

809

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

502

2332

1.41

11.48

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

7326

44079

1.10

11.46

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

224

872

1.68

11.46

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2937

16753

1.15

11.42

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

159

560

1.86

11.40

1.4

1.3

mu/l

93.0

78.5

0.27

125

420

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1204

6340

1.25

11.35

1.4

u/ml

16.1

20.0

0.59

125

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

511

2387

1.40

11.33

1.2

titre

168.2

140.8

0.14

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

341

1474

1.51

11.30

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

244

976

1.64

11.26

1.8

2.2

ug/l

60.9

59.5

0.08

238

955

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

500

2332

1.40

11.19

1.2

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1630

8871

1.21

11.17

2.8

2.4

182.1

186.0

0.99

1520

8391

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

382

1695

1.48

11.16

1.3

titre

384.6

428.5

0.08

132

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

533

2515

1.39

11.15

1.2

1.1

mg/l

39.4

42.3

0.59

452

2098

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

330

1421

1.52

11.14

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

330

1421

1.52

11.14

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

330

1421

1.52

11.14

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

499

2329

1.40

11.12

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

338

1464

1.51

11.10

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

329

1422

1.51

10.93

1.9

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

462

2135

1.42

10.91

1.8

1.9

mg/l

4.1

3.7

1.00

439

2029

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

283

1185

1.56

10.84

2.3

2.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

113

360

2.05

10.81

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

455

2102

1.42

10.77

1.4

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

945

4869

1.27

10.76

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

275

1148

1.57

10.69

1.6

1.8

umol/l

29.2

29.1

0.10

267

1105

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

562

2695

1.37

10.67

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

591

2857

1.36

10.67

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

674

3324

1.33

10.65

8.8

8.1

mmol/l

7.6

7.3

0.71

552

2695

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1697

9314

1.20

10.64

2.7

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

549

2626

1.37

10.60

3.1

2.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

577

2782

1.36

10.59

3.2

3.3

58.3

58.8

0.18

379

1748

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2601

14789

1.16

10.59

9.5

9.2

mmol/l

24.3

0.61

2417

13796

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1297

6950

1.22

10.43

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

9.80

10.36

1.1

1.0

—

(40768441) Liver Pathology biopsy report

445

2064

1.41

10.32

1.3

1.4

—

(3018133) Calcium [Moles/volume] in Urine

123

412

1.95

10.28

2.1

1.8

mmol/l

2.6

0.02

105

372

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

652

3219

1.33

10.25

1.1

au/ml

45.7

25.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

510

2425

1.38

10.23

1.1

mg/l

246.9

259.0

0.65

447

2127

(3013293) Extractable nuclear Ab [Presence] in Serum

127

431

1.93

10.23

1.7

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

368

1652

1.46

10.19

1.3

titre

65.0

68.5

0.08

138

(3010015) Selenium [Moles/volume] in Serum or Plasma

223

2.32

10.15

1.7

2.0

umol/l

1.3

0.39

198

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

370

1678

1.44

9.74

1.4

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

382

1745

1.43

9.68

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

650

3237

1.32

9.65

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1129

6015

1.23

9.64

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

855

4414

1.27

9.63

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

265

1129

1.54

9.48

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1832

10230

1.18

9.45

1.4

—

(3016750) Collection duration of Urine

357

1620

1.44

9.39

2.0

2.2

min

502.8

501.6

0.09

258

1214

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

538

2621

1.34

9.31

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

249

1051

1.55

9.30

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

218

892

1.60

9.29

3.4

3.5

52.5

53.3

0.19

212

861

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

137

494

1.81

9.23

1.6

1.4

nmol/l

0.2

0.3

0.17

104

352

(3010370) Gastrin [Moles/volume] in Serum or Plasma

122

424

1.88

9.22

2.2

1.7

pmol/l

49.2

46.0

0.14

359

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1099

5874

1.23

9.12

1.5

1.4

u/ml

112.2

110.9

0.09

274

1309

(3000034) Microalbumin [Mass/volume] in Urine

521

2534

1.35

9.12

3.3

2.9

mg/l

57.3

51.9

0.18

385

1796

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

315

1404

1.47

9.11

1.1

u/ml

7.2

10.4

1.01

250

(40757494) Bilirubin.total [Moles/volume] in Blood

326

1465

1.46

9.05

2.2

umol/l

15.7

25.9

1.61

146

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1731

9659

1.18

9.03

2.8

2.3

92.8

91.8

0.94

1583

8987

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

996

5276

1.24

9.01

1.5

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1672

9310

1.18

8.95

3.0

2.5

g/l

3.6

0.46

1576

8862

(3042631) Mycobacterium sp identified in Specimen

728

3720

1.28

8.95

2.5

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

306

1363

1.47

8.89

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

185

735

1.65

8.89

1.3

nmol/l

120.4

125.4

0.19

143

542

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

331

1499

1.45

8.84

1.7

1.8

141.1

139.5

0.13

307

1412

(3017817) Protein [Mass] in Urine collected for unspecified duration

524

2564

1.34

8.84

2.6

2.5

1.1

0.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

419

1983

1.38

8.74

1.1

ratio

1.1

0.18

157

698

(3001186) Copper [Moles/volume] in Serum or Plasma

176

694

1.66

8.72

1.3

umol/l

17.4

16.9

0.43

158

618

(3005570) Glucose [Moles/volume] in Urine

592

2957

1.31

8.66

2.1

1.8

mmol/l

6.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1985

11236

1.16

8.65

1.3

miu/ml

223.5

224.7

0.05

939

5327

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

688

3509

1.28

8.61

1.6

1.5

52.7

57.3

2.07

419

2248

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

646

3268

1.29

8.61

1.1

92.4

94.9

1.53

601

3056

(3003888) Timothy IgE Ab [Units/volume] in Serum

1082

5811

1.22

8.60

1.1

u/ml

4.5

5.4

1.13

533

2976

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.92

8.51

1.5

1.3

nmol/l

489.5

523.9

0.13

(3004451) EKG impression Narrative

285

1268

1.47

8.37

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

188

763

1.61

8.34

1.8

1.5

ug/l

9.3

9.0

0.35

188

763

(3019230) Fractional oxyhemoglobin in Venous blood

894

4723

1.24

8.33

3.8

3.1

63.5

64.4

0.57

885

4703

(3011288) Drugs identified in Urine by Screen method

1630

9120

1.17

8.27

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

256

1118

1.50

8.24

2.0

—

(3024928) Oxygen saturation in Venous blood

1089

5888

1.21

8.12

3.9

3.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1192

6502

1.20

8.11

1.1

u/ml

1.5

1.6

0.12

438

2647

(3042517) Benzodiazepines panel - Urine

104

362

1.88

7.90

3.2

3.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

432

2093

1.35

7.84

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

251

1104

1.49

7.84

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

240

1046

1.50

7.83

2.7

2.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

172

696

1.62

7.76

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

610

3110

1.28

7.71

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

249

1098

1.48

7.69

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

250

1104

1.48

7.67

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

313

1443

1.42

7.66

1.2

1.3

57.9

64.4

0.52

170

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

13.07

7.61

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

831

4402

1.24

7.60

1.5

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

1320

7312

1.18

7.59

4.4

4.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

354

1673

1.38

7.52

1.2

u/l

25.6

25.0

0.07

302

1437

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

290

1324

1.43

7.50

2.4

2.1

umol/l

161.5

130.5

0.63

146

677

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

355

1681

1.38

7.46

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

527

2648

1.30

7.46

1.5

35.6

30.8

1.94

306

1686

(3037556) Urate [Mass/volume] in Serum or Plasma

185

770

1.57

7.45

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

803

4249

1.24

7.43

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

307

1419

1.42

7.43

1.1

miu/ml

1573.9

1488.7

0.63

307

1419

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

113

413

1.79

7.39

1.7

1.4

nmol/l

63547.1

222627.0

0.89

336

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

119

442

1.76

7.38

1.4

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

327

1531

1.40

7.36

1.7

1.6

nmol/l

1.1

1.3

2.05

250

1203

(3011412) CD3 cells [#/volume] in Blood

567

2884

1.29

7.33

2.3

2.4

e9/l

1.2

0.05

339

1714

(3000330) Specific gravity of Urine by Test strip

2514

14636

1.13

7.29

3.7

3.3

—

(3021788) Differential panel - Synovial fluid

957

5168

1.21

7.28

1.6

1.5

—

(3001556) Androgen free Index in Serum or Plasma

321

1.89

7.28

1.3

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

442

2178

1.33

7.21

2.7

2.4

—

(40762365) Oxygen content in Arterial blood by calculation

116

431

1.76

7.20

2.1

3.3

ml/dl

14.9

14.7

0.26

108

397

(4027681)

401

1957

1.34

7.00

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

626

3245

1.26

6.97

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

588

3026

1.27

6.96

1.5

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

417

2050

1.33

6.94

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.47

6.92

1.5

1.4

nmol/l

142.3

140.7

0.01

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

359

1727

1.36

6.89

1.2

u/l

81.7

94.3

1.90

319

1506

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

578

2976

1.27

6.82

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

296

1.90

6.82

2.1

2.8

mmol/l

1.7

1.2

0.78

208

(3020491) Glucose [Moles/volume] in Blood

458

2290

1.31

6.78

1.8

mmol/l

6.6

0.10

312

1722

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

394

1929

1.34

6.75

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

952

5183

1.20

6.70

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

425

2107

1.32

6.69

2.0

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

546

2799

1.28

6.69

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1435

8095

1.16

6.65

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

329

1573

1.37

6.59

1.1

—

(3017704) Immunofixation for Urine

306

1446

1.38

6.58

1.5

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

394

1938

1.33

6.56

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

639

3347

1.25

6.54

2.6

2.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1011

5548

1.19

6.54

1.1

u/ml

0.8

1.2

1.76

393

2346

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

113

430

1.72

6.51

1.1

1.0

ug/l

75.8

82.1

0.85

356

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2604

15298

1.12

6.50

9.8

9.5

—

(3007916) DNA double strand Ab [Titer] in Serum

353

1.80

6.50

1.3

1.4

titre

48.3

126.1

—

(3004775) Volume in Urine collected for unspecified duration

443

2220

1.31

6.47

2.2

2.3

655.9

679.5

0.54

311

1515

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

171

724

1.54

6.47

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1221

6818

1.17

6.45

1.7

1.6

e6/l

10909.8

13523.4

1.52

902

4947

(3008037) Lactate [Moles/volume] in Venous blood

1097

6072

1.18

6.44

3.4

3.1

mmol/l

1.5

1.6

0.79

1068

5961

(3034891) Synovial lining cells/100 cells in Synovial fluid

286

1345

1.39

6.35

1.6

1.4

3.9

4.2

0.12

309

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2013

11666

1.13

6.34

4.9

5.0

1.7

0.45

1887

10958

(21494890) Protein electrophoresis panel - 24 hour Urine

543

2806

1.27

6.26

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

331

1599

1.35

6.24

1.1

—

(3051651) Icteric interference index of Serum or Plasma

355

1735

1.34

6.20

3.9

3.8

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

197

2.06

6.17

1.5

43.3

36.5

0.54

131

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

373

1839

1.33

6.15

1.7

2.2

97.5

97.7

0.04

338

1709

(21491868) Cryoglobulin [Mass/volume] in Serum

221

1000

1.45

6.10

1.2

g/l

0.5

0.09

(3014271) Vancomycin [Susceptibility]

290

1377

1.38

6.10

3.1

2.9

—

(44806118)

605

3177

1.25

6.10

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

464

2360

1.29

6.09

2.1

1.9

u/field

2.1

2.4

0.69

214

1024

(44790049)

605

3178

1.25

6.08

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

234

1071

1.43

6.08

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1792

10339

1.14

6.07

2.2

—

(44790047)

605

3179

1.25

6.06

1.5

—

(44790048)

605

3179

1.25

6.06

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

278

1313

1.39

6.04

2.6

2.1

ug/l

21.1

232.8

1.83

264

1249

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

961

5295

1.19

5.99

1.6

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

156

660

1.55

5.96

1.2

pmol/l

333.8

318.9

0.12

113

489

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

351

1726

1.33

5.91

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

218

992

1.44

5.86

1.8

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

294

1.82

5.81

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

158

676

1.53

5.76

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

235

1089

1.41

5.73

1.2

1.1

108.2

110.1

0.28

209

983

(3010503) CD19 cells [#/volume] in Blood

356

1763

1.32

5.73

2.5

2.6

e9/l

0.2

0.4

2.17

346

1716

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

166

719

1.51

5.72

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

345

1.74

5.64

1.5

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

6373

39205

1.07

5.61

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

159

686

1.52

5.59

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

122

495

1.61

5.59

5.3

4.7

u/l

41.2

59.3

1.25

193

(3047181) Lactate [Moles/volume] in Blood

1579

9089

1.14

5.58

5.7

mmol/l

1.3

0.54

1395

8058

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

170

745

1.49

5.56

2.1

1.9

u/l

27.4

40.4

1.04

149

672

(3020874) Milk IgE Ab [Units/volume] in Serum

392

1977

1.30

5.54

1.0

1.1

u/ml

0.4

3.2

1.85

118

565

(3051611) Lipemic interference index of Serum or Plasma

575

3038

1.24

5.53

3.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4380

26608

1.08

5.44

1.9

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

289

1400

1.35

5.42

1.7

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

211

970

1.42

5.41

1.0

1.1

u/ml

9.7

10.4

0.12

134

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

157

681

1.51

5.40

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

157

681

1.51

5.40

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

157

681

1.51

5.40

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

157

681

1.51

5.40

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

274

1318

1.36

5.38

3.1

3.3

—

(4015189)

161

704

1.50

5.34

2.2

—

(3024869) Neuronal Ab [Presence] in Serum

119

486

1.60

5.33

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

258

1232

1.37

5.31

10.2

3.6

mg/l

1380.7

2831.5

0.68

195

878

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

197

899

1.43

5.27

1.2

23.6

21.1

0.19

152

(3013676) Sertraline [Moles/volume] in Serum or Plasma

3.68

5.23

1.3

nmol/l

131.3

190.0

0.56

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

454

2353

1.26

5.20

1.1

1.3

u/ml

—

31.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

240

1137

1.38

5.20

1.1

ng/l

446.7

462.9

0.02

259

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

208

962

1.41

5.18

1.6

1.7

u/ml

33098.8

25989.9

0.11

125

(3049717) Cytology report of Urine Cyto stain

1835

10716

1.12

5.17

2.4

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

356

1791

1.30

5.16

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

253

1211

1.37

5.15

2.4

umol/l

55.0

53.8

0.24

196

1013

(3001686) Cold agglutinin [Titer] in Serum or Plasma

118

486

1.59

5.13

1.2

1.3

titre

39.2

174.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

135

574

1.54

5.12

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

361

1822

1.30

5.12

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

442

2289

1.26

5.11

2.0

2.1

73.0

72.9

0.06

420

2205

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

208

1.92

5.08

1.2

nmol/l

15.9

15.1

0.11

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

366

1853

1.29

5.07

1.3

1.4

mmol/l

5.6

5.5

0.84

340

1766

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

103

412

1.63

5.04

4.6

5.2

ug/min

50.4

45.4

0.33

321

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

223

1050

1.39

5.02

1.1

91.0

92.8

0.24

108

487

(3007930) Methemoglobin/Hemoglobin.total in Blood

1956

11485

1.12

5.02

5.1

5.0

0.9

0.00

1836

10782

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

111

453

1.60

5.02

2.8

1.8

mmol/l

1.2

0.53

106

433

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

276

1345

1.34

5.02

1.5

1.4

—

(3000012) Reticulocyte production index

306

1515

1.32

5.00

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

276

1346

1.34

5.00

1.5

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

227

1074

1.38

4.97

1.1

89.0

91.8

0.57

109

494

(3016879) Cocaine [Presence] in Urine

2093

12345

1.11

4.95

2.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

156

2.05

4.93

1.0

1.1

u/l

39.6

94.2

0.73

124

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

162

722

1.47

4.93

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.06

4.92

1.0

1.2

nmol/24h

109.9

97.5

0.22

(3038515) Glucose [Moles/volume] in Venous blood

1020

5748

1.16

4.92

3.6

3.2

mmol/l

7.7

7.5

0.56

994

5654

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

434

2254

1.26

4.92

1.9

2.1

13.1

13.8

0.50

201

1080

(3003740) Influenza virus B Ag [Presence] in Specimen

901

5029

1.17

4.91

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

141

612

1.51

4.89

1.1

1.0

u/ml

0.5

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

396

2037

1.27

4.86

2.4

2.6

e9/l

0.2

2.06

345

1755

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

376

1.65

4.86

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

466

2447

1.25

4.81

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

973

5475

1.16

4.80

1.1

u/ml

1.4

2.2

1.67

211

1401

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

411

2128

1.26

4.79

2.5

2.6

e6/l

700.5

750.8

0.35

175

880

(3002523) Influenza virus A Ag [Presence] in Specimen

899

5029

1.17

4.78

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

136

589

1.51

4.77

1.8

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

172

1.98

4.74

1.4

1.5

12.1

11.7

0.06

125

(3019977) pH of Arterial blood

308

1540

1.31

4.72

2.4

2.5

7.4

0.13

109

509

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

326

1643

1.30

4.71

1.8

u/field

1.7

2.6

1.78

238

1160

(3051387) C reactive protein [Mass/volume] in Capillary blood

1125

6408

1.15

4.71

3.9

3.3

mg/l

25.5

27.0

0.68

683

4053

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

406

2105

1.26

4.69

2.4

2.5

e6/l

509.3

532.8

0.36

342

1757

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

162

730

1.45

4.69

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

637

3466

1.20

4.67

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

349

1781

1.28

4.60

1.2

—

(3020650) Glucose [Presence] in Urine

174

798

1.43

4.59

1.6

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

131

568

1.51

4.59

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

829

4624

1.17

4.59

1.3

1.4

mmol/l

7.2

7.0

1.44

604

3283

(40768446) Kidney Pathology biopsy report

233

1124

1.36

4.57

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

317

1603

1.29

4.49

1.3

1.2

u/l

374.8

304.5

0.33

294

1496

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

162

737

1.44

4.48

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

850

4763

1.17

4.45

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

247

1.77

4.44

1.1

u/ml

9.8

2.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

130

568

1.50

4.41

1.1

umol/24h

0.6

0.8

0.58

282

(3015183) Erythrocyte sedimentation rate

314

1590

1.29

4.41

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

980

5560

1.15

4.37

3.1

3.3

u/ml

751.8

787.8

0.05

885

5053

(3003434) Protein [Mass/volume] in Pleural fluid

657

3610

1.19

4.36

1.6

1.4

g/l

32.6

32.9

0.21

598

3240

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

244

1.77

4.34

1.7

1.6

mg/l

1.2

1.9

1.12

155

(3023419) Bacteria identified in Sputum by Culture

630

3455

1.19

4.28

2.7

2.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

463

0.49

4.28

2.9

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

462

0.49

4.25

5.7

6.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

228

1110

1.34

4.25

1.8

159.5

160.0

0.02

216

1042

(3029075) Extractable nuclear Ab panel - Serum

190

899

1.38

4.24

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

115

495

1.52

4.21

3.4

1.8

mmol/l

1.2

0.72

110

473

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

1.1

2.5

2.00

150

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

0.6

1.0

0.83

159

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

2.7

2.0

0.38

173

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

0.5

1.3

1.58

148

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

1.4

2.7

1.87

162

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

1.3

2.3

1.41

141

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

2.3

2.6

0.14

163

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

1.5

1.9

0.39

168

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

237

1.77

4.20

1.7

1.5

mg/l

2.4

4.3

1.89

146

(3000764) Benzodiazepines [Presence] in Urine

2230

13318

1.10

4.18

2.1

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

786

4402

1.17

4.18

1.1

u/ml

4.7

5.2

0.17

298

1842

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

283

1425

1.30

4.18

1.1

95.9

96.0

0.02

216

1133

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

167

775

1.41

4.17

1.2

—

(3027008) Opiates [Presence] in Urine

2241

13398

1.10

4.12

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

2245

13433

1.10

4.06

2.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

155

1.94

4.04

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

295

1.66

4.00

2.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

208

1.79

3.95

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

832

4704

1.16

3.94

1.1

u/ml

3.1

4.9

2.29

299

1869

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

262

1.70

3.92

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

430

1.54

3.91

1.2

1.1

u/ml

0.1

0.4

0.63

275

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

109

472

1.51

3.91

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

122

541

1.47

3.91

2.7

2.3

mmol/l

7.4

7.5

0.07

335

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

394

1.56

3.90

1.3

1.4

37.3

54.1

2.59

182

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

181

865

1.37

3.84

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

389

2060

1.24

3.82

1.7

1.5

umol/l

62.7

69.2

1.18

173

(3024263) Appearance of Synovial fluid

285

1456

1.28

3.81

2.1

1.6

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.92

3.80

1.0

1.5

nmol/l

316.5

286.5

0.33

(40768806) Pleura Pathology biopsy report

512

2789

1.20

3.80

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

158

740

1.40

3.79

1.4

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

186

895

1.36

3.79

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

677

3786

1.17

3.72

1.0

u/ml

0.4

0.07

119

829

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

377

1998

1.23

3.69

1.5

1.4

u/l

12.9

12.7

0.15

366

1925

(40763791) Oxygen content in Venous blood by calculation

2.45

3.69

4.3

6.4

ml/dl

13.4

11.9

0.84

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

129

586

1.44

3.68

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

370

1959

1.24

3.66

1.0

1.1

u/ml

2.9

4.0

0.21

483

(3034426) Prothrombin time (PT)

208

1026

1.33

3.62

1.2

—

(44806071)

402

1.53

3.60

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

870

1.35

3.59

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

131

600

1.43

3.59

1.1

u/ml

—

23.7

—

(3028433) Virus identified in Specimen by Culture

196

960

1.34

3.58

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

200

984

1.33

3.55

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

357

1.56

3.54

2.6

pmol/l

61.1

64.3

0.14

307

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1093

6347

1.13

3.53

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

203

1002

1.32

3.53

1.1

—

(3012441) Differential panel - Pleural fluid

509

2794

1.19

3.51

1.6

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

332

1.58

3.51

1.0

u/ml

0.0

0.2

2.02

198

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1093

6350

1.13

3.50

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3432

21022

1.07

3.50

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

667

3750

1.16

3.46

7.0

6.1

mg/l

11.7

11.6

0.40

601

3450

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

733

5510

0.87

3.45

1.2

—

(3042733) HLA Ab [Presence] in Serum

197

972

1.33

3.44

5.2

4.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

811

4627

1.15

3.44

3.7

3.5

u/ml

36.3

38.6

0.16

783

4456

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

324

1704

1.24

3.44

1.0

ng/l

38.9

43.5

0.83

211

1204

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

146

1.88

3.43

1.3

1.4

0.9

2.0

0.96

(3017509) Phencyclidine [Presence] in Urine

360

1.54

3.42

2.0

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

231

1167

1.29

3.41

2.7

2.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

323

1701

1.24

3.39

1.0

ng/l

781.7

732.1

1.06

204

1188

(21494815) CD4 cells/100 lymphocytes in Specimen

466

2549

1.20

3.36

2.1

2.2

41.3

41.6

0.07

341

(3014051) Protein [Presence] in Urine by Test strip

1172

6856

1.12

3.36

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4201

29026

0.94

3.35

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

576

3212

1.17

3.33

1.4

mmol/l

12.3

11.6

0.78

133

669

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

245

1.65

3.32

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

177

866

1.34

3.30

1.9

2.2

e6/l

195.7

851.8

1.31

104

462

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

172

1.79

3.29

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

287

1498

1.25

3.28

3.6

2.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

248

1272

1.28

3.28

39.3

35.1

ug/l

7.4

7.3

0.62

230

1150

(3016228) CD19 cells/100 cells in Blood

228

1158

1.29

3.26

1.9

2.1

9.4

8.4

0.53

222

1130

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

459

2517

1.19

3.24

1.6

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

231

1179

1.28

3.18

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

393

1.50

3.18

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

223

1134

1.29

3.17

1.9

2.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

319

1693

1.23

3.15

1.0

ng/l

287.0

347.5

1.64

211

1220

(3022475) Manganese [Moles/volume] in Blood

170

1.77

3.13

1.2

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1315

9480

0.90

3.12

1.4

1.5

—

(3019174) dRVVT (LA screen)

275

1.59

3.12

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

240

1235

1.27

3.11

2.0

2.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

260

1.61

3.10

1.1

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

3.15

3.09

1.1

—

(3027944) Amphetamines [Presence] in Urine

2180

13199

1.08

3.09

2.1

2.0

—

(3051339) Copper [Moles/volume] in Blood

147

1.82

3.08

1.1

1.3

umol/l

16.8

0.03

126

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.28

3.08

8.2

8.4

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.28

3.08

1.0

u/ml

0.0

0.2

0.82

(4211845)

310

1646

1.23

3.06

3.5

2.8

—

(3005033) Fetal Nuchal fold Thickness US

1314

9460

0.91

3.05

1.4

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.37

3.05

3.5

2.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

440

1.46

3.04

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

505

1.42

3.04

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

148

1.81

3.02

1.7

umol/l

0.8

0.7

0.45

113

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

104

473

1.44

3.02

2.3

2.6

mg/l

124.0

51.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

298

1.56

3.02

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

372

2016

1.21

3.01

1.7

—

(4281824)

559

3139

1.17

3.01

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

458

1.44

2.99

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

122

573

1.39

2.97

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

122

573

1.39

2.97

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

122

573

1.39

2.97

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

726

4159

1.14

2.97

1.2

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

1.70

2.96

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

132

629

1.37

2.95

2.3

2.7

ng/l

89.2

98.7

0.24

307

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

365

1.49

2.88

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

765

4410

1.14

2.86

1.7

2.0

titre

9.5

6.6

—

(3013466) aPTT in Blood by Coagulation assay

195

1.68

2.86

1.2

1.1

35.1

37.4

2.19

162

(3010144) Erythrocytes [#/volume] in Synovial fluid

477

2658

1.17

2.85

1.4

e6/l

117431.2

114694.7

0.03

328

1823

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

269

1420

1.24

2.84

1.8

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

186

939

1.30

2.84

1.5

1.4

59.8

62.6

0.47

149

769

(3006969) Lambda light chains [Mass/volume] in Urine

2.33

2.84

1.0

1.1

g/l

0.0

0.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.61

2.83

4.5

4.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

576

3260

1.16

2.82

1.6

1.5

e6/l

4437.1

2996.7

0.36

409

2367

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.07

2.81

1.0

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.01

2.81

1.0

u/ml

0.1

0.31

(40763480) Human metapneumovirus Ag [Presence] in Specimen

128

1.84

2.80

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1354

9681

0.91

2.76

1.5

—

(36304079) Mucus [Presence] in Urine sediment

4.75

2.73

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

528

0.63

2.72

1.7

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

183

1.68

2.72

4.3

4.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

193

1.66

2.72

1.0

—

(3003129) Base excess in Capillary blood by calculation

139

678

1.34

2.72

1.7

mmol/l

0.7

0.5

0.28

133

635

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

226

1177

1.26

2.71

1.0

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

111

1.88

2.69

1.0

u/ml

0.1

0.21

(3028717) Thiamine [Mass/volume] in Blood

302

1.52

2.68

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

163

816

1.31

2.67

1.3

g/l

37.8

40.1

1.24

436

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

181

921

1.29

2.63

3.0

3.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

170

1.69

2.63

1.2

1.1

u/field

1.3

1.2

0.53

112

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1662

11749

0.92

2.62

1.9

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

138

677

1.33

2.61

1.2

1.1

83.9

86.9

0.29

168

(1617658) Protocol used for examination of sentinel lymph nodes

388

2143

1.18

2.61

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

6.53

2.61

1.2

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

871

1.29

2.60

2.5

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

871

1.29

2.60

2.5

2.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

211

1.61

2.59

2.9

3.6

mg/l

2.3

2.2

0.11

179

(3044242) Glucose [Moles/volume] in Arterial blood

246

1301

1.24

2.59

1.7

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

375

2067

1.19

2.59

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

113

1.85

2.57

1.1

u/l

236.6

376.6

1.11

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

137

1.77

2.56

8.8

11.3

e6/l

165.6

370.6

0.84

101

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.09

2.56

1.0

1.2

pmol/l

477.9

337.7

0.24

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.02

2.55

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

104

1.89

2.54

1.1

u/field

1.1

1.3

0.27

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

657

3789

1.13

2.50

2.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

184

947

1.27

2.47

1.1

u/ml

1.0

13.8

0.69

540

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

347

1909

1.19

2.47

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

257

1374

1.22

2.46

1.2

—

(4198724)

269

1445

1.22

2.46

1.9

2.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

134

1.76

2.46

1.2

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.22

2.44

1.0

u/ml

0.0

0.16

(3015076) Soybean IgE Ab [Units/volume] in Serum

325

1780

1.19

2.43

1.0

u/ml

0.2

0.8

1.27

254

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

304

1.48

2.43

1.0

u/ml

0.0

0.3

1.07

166

(3036782) Glucose [Moles/volume] in Pleural fluid

455

2564

1.16

2.42

1.4

1.3

mmol/l

6.4

6.3

0.51

429

2357

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

318

1740

1.20

2.41

1.7

1.9

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

4.02

2.41

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

4.02

2.41

1.0

1.1

—

(3035880) pH of Pleural fluid

269

1450

1.21

2.39

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

142

710

1.31

2.39

1.2

105.0

108.1

0.44

135

667

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

354

1.44

2.37

2.1

1.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

442

1.39

2.36

2.3

2.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

181

1.63

2.35

1.1

u/ml

0.1

1.8

2.06

124

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

359

1991

1.18

2.35

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1634

9904

1.08

2.34

1.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

435

2451

1.16

2.33

1.3

u/l

445.5

491.1

0.16

413

2316

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

110

532

1.35

2.33

1.1

u/ml

1.2

4.2

1.30

380

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

252

1354

1.22

2.33

1.5

1.6

iu/ml

2019310.1

1861512.7

0.05

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

122

1.77

2.32

1.5

1.6

u/l

0.1

0.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

313

1.46

2.31

1.0

u/ml

0.0

1.6

0.77

167

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1775

10806

1.08

2.28

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

858

5058

1.11

2.28

1.6

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

135

676

1.31

2.27

1.2

1.1

71.0

74.9

0.34

161

(3002079) Sodium [Moles/time] in 24 hour Urine

2.57

2.26

1.3

1.0

mmol/24h

138.8

139.7

0.02

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2840

19595

0.94

2.26

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

143

1.69

2.25

1.2

1.3

u/ml

17.3

21.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

392

0.62

2.25

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

109

1.80

2.24

1.4

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

326

1.44

2.24

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

712

1.29

2.23

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

244

1314

1.21

2.22

3.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

223

1190

1.23

2.22

2.0

2.3

11.3

10.4

0.49

203

1111

(3037692) Legionella sp identified in Specimen by Organism specific culture

185

968

1.25

2.20

1.3

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

218

1163

1.23

2.18

1.9

2.1

28.0

29.3

0.65

203

1106

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

180

1.60

2.18

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1356

8189

1.08

2.16

1.5

—

(3048879) Bone marrow aspiration report

154

791

1.27

2.15

1.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

275

1.47

2.15

1.2

1.3

mmol/l

6.0

6.1

0.05

140

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

286

1.46

2.14

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.88

2.14

2.5

2.0

—

(40768795) Lymph node Pathology biopsy report

491

2813

1.14

2.13

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

752

4424

1.11

2.10

1.5

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

353

1.41

2.08

1.6

ug/l

116.5

110.5

0.18

294

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

246

1336

1.20

2.08

1.6

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

288

1.45

2.08

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

516

2972

1.14

2.07

1.6

1.4

e6/l

50518.5

57340.2

0.20

306

1782

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

246

1337

1.20

2.06

1.6

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

127

1.70

2.06

1.0

u/ml

0.1

0.2

0.06

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

332

1.42

2.06

4.1

2.9

umol/l

38.6

41.4

0.45

280

(3014891) Appearance of Pleural fluid

360

1.40

2.04

1.8

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

248

1351

1.20

2.04

2.2

2.1

ug/min

104.3

99.5

0.04

305

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

606

3530

1.12

2.03

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

671

1.29

2.02

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

323

1.42

2.00

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

239

1301

1.20

1.99

8.0

10.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

132

673

1.28

1.98

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

469

2696

1.14

1.96

3.4

3.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

319

1.41

1.96

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

179

948

1.23

1.96

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.79

1.94

1.0

1.1

nmol/l

233.7

261.7

0.32

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

386

1.37

1.94

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

160

1.59

1.94

1.4

1.8

ug/g

158.8

180.7

0.42

140

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.52

1.94

1.0

1.1

umol/l

21.6

34.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

286

1587

1.18

1.93

1.6

1.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

145

1.62

1.92

1.4

1.3

u/l

743.8

1160.5

0.19

130

(3016031) Almond IgE Ab [Units/volume] in Serum

213

1.50

1.91

1.1

1.0

u/ml

0.2

0.7

2.86

118

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

166

1.57

1.90

5.1

5.0

—

(3045788) Cell count panel - Pleural fluid

439

2520

1.14

1.89

1.6

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.87

1.88

1.5

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

671

3955

1.11

1.86

2.5

u/ml

562.5

895.1

0.36

649

3724

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

188

1.53

1.86

1.6

1.3

pmol/l

13.5

18.4

1.51

161

(3039000) Anion gap in Blood

1061

6397

1.09

1.82

6.8

6.7

mmol/l

11.2

0.17

957

5782

(3001893) Eosinophils/100 leukocytes in Pleural fluid

153

804

1.24

1.82

1.5

1.4

3.3

2.7

0.28

125

672

(3045142) Bone marrow Pathology biopsy report

516

3001

1.12

1.82

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

122

624

1.28

1.82

1.4

20.1

22.9

0.54

103

515

(3018572) Chloride [Moles/volume] in Blood

1061

6398

1.09

1.82

6.8

6.7

mmol/l

105.3

105.2

0.21

958

5783

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

104

521

1.30

1.81

2.6

2.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

414

1.34

1.80

2.7

3.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

638

3760

1.11

1.79

1.5

1.7

titre

3806.7

2670.6

0.22

123

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

288

1.41

1.75

1.0

u/ml

0.1

0.6

1.72

159

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.74

1.73

1.2

1.0

g/l

0.2

0.23

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

172

1.52

1.67

1.1

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1681

11653

0.94

1.66

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

137

721

1.24

1.64

1.5

1.3

24.8

21.0

0.77

121

650

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

259

1.41

1.64

1.0

1.2

mg/l

53.9

45.2

0.36

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1681

11646

0.94

1.63

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

147

1.56

1.62

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

200

1.47

1.62

1.0

1.1

u/l

14.0

9.5

0.34

200

(3023383) Lactate [Moles/volume] in Pleural fluid

151

805

1.23

1.62

1.3

mmol/l

3.3

3.6

0.56

134

736

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1674

11590

0.94

1.60

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

389

1.33

1.59

1.5

1.4

13.8

10.7

0.37

196

(3036180) Methadone [Presence] in Urine

1.92

1.59

2.6

3.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

169

1.51

1.59

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

117

1.62

1.58

1.1

1.4

u/field

1.5

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.73

1.58

1.1

1.2

ng/l

2612.6

2345.7

0.08

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

103

527

1.28

1.58

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

103

528

1.28

1.56

1.1

1.2

u/ml

0.1

9.4

1.57

117

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.94

1.54

1.1

1.9

2.7

0.66

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1681

11622

0.94

1.54

1.4

—

(3012898) Urea [Moles/volume] in Urine

296

1.37

1.53

1.2

1.7

mmol/l

161.4

172.1

0.29

266

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

139

1.55

1.53

1.2

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

230

1.42

1.53

1.1

iu/ml

27.8

14.8

0.47

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.71

1.53

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

252

1.40

1.52

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

109

565

1.26

1.52

1.9

1.8

ug/l

4.7

3.2

0.24

346

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1617

9975

1.06

1.51

3.0

3.4

u/ml

1157.1

2078.5

0.61

1354

8583

(3035082) Kappa light chains [Mass/volume] in Urine

1.84

1.50

1.0

1.1

g/l

0.5

0.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.96

1.50

1.1

1.2

—

(40758358) Immune stain study

119

1.59

1.50

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

188

1.46

1.48

1.5

1.7

1.1

0.7

0.38

148

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

221

1.42

1.47

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

205

1.43

1.46

2.4

2.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

470

1.28

1.45

1.2

1.4

ng/l

1136.4

100.6

0.53

299

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

243

1369

1.16

1.45

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.81

1.44

9.5

7.9

48.1

43.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

185

1427

0.85

1.44

4.5

5.9

u/ml

2521.2

3343.3

0.11

279

(3018001) Oat IgE Ab [Units/volume] in Serum

217

1.42

1.43

1.0

u/ml

0.1

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

260

1475

1.15

1.42

1.1

iu/ml

3.5

4.2

—

125

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.18

1.42

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.18

1.42

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.18

1.42

2.0

—

(3049233) Organic acids panel - Urine

2.18

1.42

1.1

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.18

1.42

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.18

1.42

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.18

1.42

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

262

1.37

1.40

1.5

1.3

mg/24h

206.9

345.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

113

595

1.24

1.40

4.2

6.3

69.6

70.3

0.11

471

(3029612) Listeria sp Ab [Titer] in Serum

1.75

1.38

1.3

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

233

1315

1.16

1.37

26.5

28.6

ug/l

117.9

118.0

0.01

181

1118

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

335

1941

1.13

1.35

1.3

u/l

12.8

13.9

0.36

308

1789

(3045716) Anion gap in Serum or Plasma

228

1287

1.16

1.35

2.1

2.5

mmol/l

9.3

9.1

0.23

168

949

(3025315) Body weight

253

1.37

1.35

4.5

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.62

1.34

1.0

u/ml

0.6

0.3

0.30

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1806

12394

0.95

1.31

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

426

1.27

1.29

2.7

2.6

u/l

1400.7

1669.0

0.09

380

(3024932) HLA-DR beta [Type]

175

971

1.18

1.29

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

167

1.45

1.29

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

222

1.38

1.28

2.4

2.6

—

(3027874) Urate [Moles/volume] in Urine

1.63

1.28

1.1

mmol/l

1.8

1.7

0.09

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

151

1.47

1.28

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

157

864

1.19

1.28

1.3

1.4

48.0

55.1

1.40

123

753

(3008536) Aspergillus sp Ab [Presence] in Serum

105

556

1.23

1.26

1.9

2.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

434

1.27

1.25

1.7

1.6

—

(3024471) HLA-A [Type]

179

999

1.17

1.25

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3481

21993

1.04

1.23

1.5

—

(40762814) Titanium [Mass/volume] in Blood

441

1.26

1.23

2.1

2.3

ug/l

3.9

3.5

0.26

151

(40762887) Creatinine [Moles/volume] in Blood

1.77

1.23

1.0

1.3

—

(37019676) Renin [Units/volume] in Plasma --supine

1.77

1.23

1.1

mu/l

20.0

58.4

—

(3047189) Immunofixation for 24 hour Urine

220

1250

1.15

1.22

1.8

—

(3026726) Creatinine [Moles/volume] in Specimen

236

1.36

1.21

2.7

2.4

umol/l

709.7

323.4

0.60

226

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

293

1.32

1.19

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

385

1.27

1.19

2.1

2.5

u/field

0.7

0.6

0.45

385

(44786800) Granulocytes/100 leukocytes in Body fluid

339

1.29

1.19

1.4

1.3

25.4

24.6

0.07

262

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

155

1188

0.85

1.18

2.9

3.1

mg/l

7.8

8.0

0.18

127

943

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

111

597

1.22

1.17

1.2

mg/l

0.8

55.1

2.66

438

(40765089) Chromosome analysis panel - Blood by G-banded

176

988

1.16

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.57

1.15

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

107

1.53

1.13

10.4

15.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

183

1.39

1.13

1.1

u/ml

3.7

8.0

1.99

131

(3020123) Porphyrins [Interpretation] in Serum or Plasma

183

1.39

1.13

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

518

1.22

1.11

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

424

1.25

1.11

1.9

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

124

1.48

1.10

1.0

—

(36303858) Crystals [Presence] in Urine

1.87

1.08

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

627

1.20

1.08

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.53

1.07

1.0

1.1

pmol/l

118.9

248.2

1.79

(4212803)

236

1.33

1.06

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

305

1.29

1.06

1.1

1.0

u/ml

0.6

1.3

0.45

228

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

158

1.41

1.06

1.6

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

152

852

1.17

1.05

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

134

744

1.18

1.04

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

181

1.37

1.03

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

488

1.22

1.03

5.1

5.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

365

1.25

1.02

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

199

1.35

1.00

1.0

u/ml

0.4

2.1

1.28

153

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

117

645

1.19

1.00

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

496

1.21

0.99

1.2

mmol/l

1.6

1.7

0.09

301

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.57

0.99

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

138

772

1.17

0.99

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

263

1.29

0.97

1.7

1.5

—

(3001729) Color of Synovial fluid

223

1.32

0.97

1.5

1.6

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.78

0.96

1.0

u/ml

0.3

0.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.73

0.96

1.0

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.31

0.95

1.0

1.2

nmol/24h

14.0

34.8

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

387

1.23

0.94

1.2

1.3

mmol/l

1.5

1.3

0.18

246

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

225

1.31

0.92

2.1

2.2

53.0

60.2

0.52

137

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

146

1.39

0.92

3.9

3.5

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

135

1.40

0.92

4.2

3.3

estimate

0.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

424

1.22

0.91

1.2

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.66

0.91

2.3

2.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.70

0.91

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.55

0.90

1.1

1.0

u/ml

0.0

0.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

278

1.27

0.90

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

308

1.25

0.88

1.0

u/ml

3.9

1.1

0.33

229

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.87

0.87

1.3

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

251

1.28

0.86

1.1

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.70

0.85

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

111

620

1.17

0.85

1.2

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

338

2023

1.09

0.85

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.54

0.84

1.1

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

560

3422

1.07

0.84

1.8

1.9

ug/l

20.0

24.3

2.36

547

3352

(3003577) Lead [Moles/volume] in Blood

218

0.72

0.83

1.3

1.4

umol/l

0.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

146

1087

0.88

0.83

2.5

2.6

au/ml

163.4

144.1

0.16

158

(3002331) Protein [Mass/volume] in Peritoneal fluid

106

592

1.17

0.82

1.6

1.3

g/l

26.8

38.6

0.60

458

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

195

1.31

0.82

1.0

u/ml

0.1

0.6

1.72

178

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

119

671

1.16

0.82

1.2

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

119

671

1.16

0.82

1.4

g/l

12.9

13.6

0.35

507

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

283

1.25

0.80

1.1

umol/24h

1.7

0.17

283

(3003721) Smooth muscle Ab [Units/volume] in Serum

219

1.28

0.80

1.1

u/ml

3.4

2.4

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.87

0.79

1.0

2.4

—

(3022229) Phosphate [Moles/volume] in Urine

140

1.35

0.77

1.7

1.9

mmol/l

24.7

18.9

1.10

116

(3013762) Body weight Measured

107

0.61

0.77

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

124

706

1.15

0.76

1.1

mg/g

6.2

6.5

0.26

117

669

(3041672) Baker's yeast Ab [Presence] in Serum

146

1.34

0.76

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.55

0.74

4.7

5.5

mmol/l

0.3

0.2

—

(21494434) Karyotype in Bone marrow

392

2380

1.08

0.73

1.1

1.2

—

(3009754) Celery IgE Ab [Units/volume] in Serum

1.63

0.73

1.0

u/ml

0.1

0.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.76

0.71

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

390

1.19

0.70

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.92

0.70

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

344

2084

1.08

0.69

1.2

—

(3044007) Cell count panel - Peritoneal fluid

133

768

1.13

0.69

1.6

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

201

1.27

0.69

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

155

1.31

0.68

1.0

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

184

1.28

0.68

1.0

1.1

u/ml

23.4

22.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

184

1.28

0.68

1.0

1.1

u/ml

21.3

28.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

170

998

1.11

0.68

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

146

850

1.12

0.67

1.9

1.7

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

1.82

0.66

1.2

1.0

umol/l

15.2

17.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.49

0.66

1.0

u/ml

0.5

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.49

0.66

3.4

5.3

mg/l

9.1

4.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

315

1.20

0.65

1.1

—

(4133840)

115

852

0.88

0.65

1.3

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.42

0.64

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.45

0.64

3.9

3.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

174

1027

1.11

0.64

6.6

6.1

mmol/l

24.5

25.1

1.10

162

932

(3012989) Citrate [Moles/time] in 24 hour Urine

1.52

0.63

1.2

1.4

mmol/24h

2.4

2.2

0.29

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

151

1096

0.90

0.62

1.8

2.0

mg/l

9.0

9.4

0.35

120

887

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

204

1458

0.91

0.61

1.4

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.54

0.61

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

213

0.77

0.61

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

199

1187

1.10

0.60

2.7

3.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

409

1.17

0.60

10.3

7.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

156

920

1.11

0.60

1.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.54

0.59

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

343

1.18

0.59

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

302

1836

1.08

0.59

1.4

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

273

1.20

0.56

1.1

u/l

18.2

21.4

0.82

173

(3006598) pH of Arterial cord blood

128

0.71

0.55

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

103

1.33

0.55

1.9

2.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

238

1.21

0.54

1.2

ug/l

97.8

107.9

0.22

138

(3004446) Plasmodium sp identified in Blood by Light microscopy

359

0.84

0.54

2.2

2.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

470

0.86

0.52

8.9

7.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

207

0.79

0.51

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

240

1.20

0.51

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

187

1.22

0.50

1.1

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

204

1235

1.08

0.48

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

101

591

1.12

0.48

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.48

0.47

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

153

0.77

0.46

1.0

u/ml

0.1

9.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

340

1.15

0.46

1.5

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

171

1.22

0.46

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

271

1662

1.07

0.46

2.7

41.7

39.2

0.90

581

(3023487) Leukocytes [#/volume] in Peritoneal fluid

162

975

1.09

0.45

2.0

e6/l

1603.8

3584.0

0.75

108

662

(3000285) Sodium [Moles/volume] in Blood

347

1.15

0.45

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

178

1.21

0.44

2.1

2.2

16.4

16.9

0.03

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

336

1.15

0.43

1.2

1.3

u/l

87.2

257.1

0.58

242

(3002621) Streptococcal DNAse B [Units/volume] in Serum

286

0.85

0.42

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.56

0.42

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.37

0.41

1.0

1.4

e6/l

16.6

61.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

144

867

1.09

0.41

1.8

1.9

e6/l

6393.5

11942.4

0.96

466

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

306

0.85

0.41

4.2

2.7

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.49

0.40

1.0

1.6

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.49

0.40

1.2

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

211

1291

1.07

0.40

1.1

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

364

1.13

0.39

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.31

0.39

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

259

1598

1.06

0.39

1.2

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.37

0.39

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.42

0.38

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

218

1.17

0.38

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

304

1.14

0.37

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

176

1.19

0.37

1.2

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

125

883

0.92

0.36

1.5

1.7

au/ml

77.3

137.9

0.66

116

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.25

0.36

2.0

2.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

244

1.15

0.35

1.5

1.3

ml/s/173m2

1.1

1.5

0.62

161

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

123

744

1.08

0.34

1.3

ug/l

110.9

294.4

1.41

394

(44806420)

124

751

1.08

0.33

2.4

2.3

—

(40757373) Influenza virus identified in Isolate

575

1.09

0.33

1.5

1.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

160

1.18

0.33

1.1

1.0

—

(3032641) Amino acids panel - Urine

1.31

0.33

1.5

1.4

—

(3041184) Isoniazid [Presence] in Urine

1.35

0.31

2.0

2.6

—

(3049242) von Willebrand panel - Platelet poor plasma

1.24

0.31

1.3

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

278

1.13

0.31

8.5

6.9

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

165

0.83

0.31

1.1

1.4

—

19393.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.31

0.31

1.0

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.31

0.30

1.2

1.4

0.2

0.5

0.62

(3011544) Albumin [Mass/volume] in Pleural fluid

248

1.13

0.30

1.2

1.1

g/l

15.9

17.4

0.68

224

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

175

1.16

0.29

1.1

u/l

2.5

2.8

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

370

0.90

0.28

8.6

8.4

umol/l

0.3

0.02

331

(3026470) Cobalt [Mass/volume] in Blood

264

1653

1.04

0.27

2.0

ug/l

4.5

3.6

0.53

231

1456

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

134

0.83

0.27

1.1

—

(3025577) Chromium [Mass/volume] in Blood

257

1609

1.04

0.26

2.0

2.1

ug/l

2.8

2.2

0.72

211

1353

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

531

3370

1.03

0.26

1.5

1.6

mmol/l

7.7

7.5

1.16

344

1978

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

332

2090

1.04

0.26

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

251

0.89

0.25

1.4

1.3

mmol/l

21.1

21.2

0.07

188

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.21

0.25

1.0

u/ml

0.3

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

339

0.91

0.24

2.2

1.9

mmol/l

6.6

7.4

0.81

131

(40758292) HTLV I+II Ab panel - Serum

488

0.92

0.24

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

111

0.82

0.24

1.5

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

117

1.17

0.23

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

222

1.12

0.23

5.1

5.7

—

(3020393) Adenovirus Ag [Presence] in Stool

323

1.09

0.22

1.3

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

224

1406

1.04

0.22

1.3

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.22

0.0

2.7

—

3.6

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.9

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.3

—

2.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

106

1.17

0.21

1.0

u/ml

0.2

0.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

721

4618

1.02

0.20

3.1

2.5

13.2

13.1

1.28

711

4562

(3034614) HLA Ag [Interpretation]

0.77

0.20

1.0

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

132

1.14

0.19

1.1

1.2

g/l

0.1

0.31

(3032352) Blasts [#/volume] in Cerebral spinal fluid

314

1.08

0.19

2.2

2.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

224

1515

0.97

0.18

1.6

1.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

308

1.08

0.18

1.1

1.3

mmol/l

—

1.5

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.16

0.16

1.1

1.0

titre

1860.0

1823.3

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.17

0.16

1.1

1.0

u/ml

0.0

0.1

—

(3033799) Differential panel - Peritoneal fluid

136

853

1.04

0.16

2.0

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

465

3102

0.98

0.16

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

503

0.95

0.14

6.1

5.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

179

1.10

0.14

1.3

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

391

2503

1.02

0.14

1.5

promille

1.3

1.4

0.71

292

1934

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

319

1.07

0.14

1.3

1.4

73.5

71.7

0.17

262

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.16

0.14

1.0

u/l

427.8

332.7

0.15

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

135

851

1.04

0.13

1.2

—

(3007463) Buprenorphine [Presence] in Urine

136

1.11

0.13

5.0

8.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

947

6116

1.01

0.13

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

124

1.11

0.12

8.7

9.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

117

0.89

0.11

1.3

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

188

1.08

0.11

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.16

0.11

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

195

1.07

0.10

1.8

2.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

227

1.07

0.10

1.1

1.0

u/ml

0.4

0.7

0.20

146

(3018851) Theophylline [Moles/volume] in Serum or Plasma

253

1.06

0.10

1.8

1.7

umol/l

45.8

0.00

253

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.09

0.10

1.2

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

102

0.90

0.09

1.0

1.1

mmol/l

7.3

5.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.15

0.08

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.12

0.08

1.1

1.0

—

(3022670) pH of Venous cord blood

0.88

0.08

1.1

—

(40760410) HLA-B [Type] by High resolution

108

1.09

0.08

1.1

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

108

1.09

0.08

1.1

1.0

—

(40760409) HLA-A [Type] by High resolution

108

1.09

0.08

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

309

1991

1.01

0.07

1.4

1.3

pmol/l

267.0

84.3

0.48

139

639

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

185

1.06

0.07

1.1

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

134

0.93

0.07

1.1

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.86

0.07

1.1

—

(46236302) HLA-C [Type] by High resolution typing

109

1.08

0.06

1.1

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

186

1.05

0.06

1.1

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.10

0.06

1.1

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

116

1.07

0.05

1.5

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.09

0.05

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

213

1.04

0.05

2.9

2.4

24.8

12.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

429

0.97

0.05

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

622

1.02

0.04

2.2

2.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

610

1.02

0.04

9.1

8.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.92

0.04

7.0

6.7

—

(4038314)

124

1.05

0.03

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.07

0.03

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2229

14593

1.00

0.03

1.5

1.4

—

(3024316) Viscosity of Plasma

150

0.96

0.03

1.0

1.8

mpas

1.3

1.7

3.92

(3050794) Legionella sp Ab [Presence] in Serum

255

0.97

0.02

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

113

747

0.99

0.02

1.3

40.2

39.1

0.11

501

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.07

0.02

1.1

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

175

0.97

0.01

1.0

1.1

u/ml

0.3

10.7

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

142

0.97

0.01

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

315

1.02

0.01

2.8

3.1

mg/l

1.1

1.2

0.29

226

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.07

0.01

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

293

1919

1.00

0.00

1.3

g/l

1.5

0.09

118

(3033942) Copper [Moles/time] in 24 hour Urine

141

0.97

0.00

1.2

1.1

umol/24h

1.6

0.6

—

(40763590) HLA-DQ beta [Type]

108

1.03

0.00

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

194

1.01

0.00

1.4

umol/24h

331.0

327.7

0.03

194

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

329

0.99

0.00

1.9

1.7

mg/l

1.9

1.6

0.56

278

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

472

1.00

0.00

1.3

1.2

—

(3013862) HLA-DP [Type]

111

1.00

0.00

1.1

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.99

0.00

1.1

mmol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

156

1.01

0.00

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

238

0.99

0.00

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

107

701

1.00

0.00

9.0

8.6

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

0.0

2.2

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.8

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.02

0.00

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.96

0.00

1.2

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.95

0.00

1.4

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.95

0.00

3.0

4.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.02

0.00

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.93

0.00

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.93

0.00

1.8

2.3

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

79.5

—

(3018291) Platelet Ab [Presence] in Serum

1.01

0.00

1.3

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.96

0.00

1.2

1.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.99

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_THYROID and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_THYROID	0.976 [0.9, 1.05]	0.526
Birth year	0.998 [0.99, 1.01]	0.568

During the follow-up period (1.1.1998 — 31.12.2019), 43600 out of 324502 females with E4_THYROID died.

Males

Parameter	HR [95% CI]	p-value
E4_THYROID	1.205 [1.1, 1.32]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 21205 out of 91502 males with E4_THYROID died.

Mortality risk

Mortality risk for people of age

years, who have E4_THYROID.

N-year risk	Females	Males
1	0.089%	0.186%
5	0.464%	1.227%
10	1.35%	3.409%
15	2.653%	6.383%
20	4.816%	11.129%

Relationships between endpoints

↥

Index endpoint: E4_THYROID – Disorders of the thyroid gland

GWS hits: 172

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of the thyroid gland

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints